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Abstract
The most common ocular tumors in the eye are retinoblastoma and uveal melanoma, affecting
children and adults respectively, and spreading throughout the body if left untreated. To date,
detection and treatment of such tumors rely mainly on two imaging modalities: Fundus
Image Photography (Fundus) and Ultrasound (US), however, other image modalities such as
Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) are key to confirm a
possible tumor spread outside the eye cavity. Current procedures to select the best treatment
and follow-up are based on manual multimodal measures taken by clinicians. These tasks
often require the manual annotation and delineation of eye structures and tumors, a rather
tedious and time consuming endeavour, to be performed in multiple medical sequences
simultaneously.
This work presents a new set of image processing methods for improving multimodal evalua-
tion of intra-ocular tumors in 3D MRI and 2D Fundus. We first introduce a novel technique
for the automatic delineation of ocular structures and tumors in the 3D MRI. To this end, we
present an Active Shape Model (ASM) built out of a dataset of healthy patients to demonstrate
that the segmentation of ocular structures (e.g. the lens, the vitreous humor, the cornea and
the sclera) can be performed in an accurate and robust manner. To validate these findings,
we introduce a set of experiments to test the model performance on eyes with presence of
endophytic retinoblastoma, and discover that the segmentation of healthy eye structures is
possible, regardless of the presence of the tumor inside the eyes. Moreover, we propose a
specific set of Eye Patient-specific eye features that can be extracted from the segmentation of
the eye in the 3D MRI, providing rich shape and intensity information of pathological tissue
while embedded in the healthy eye structures. This information is later used to train a set
of classifiers (Convolutional Neural Networks (CNN), Random Forest, ...) that enable the
automatic segmentation of ocular tumors inside the eye.
To conclude, we present a new method for the evaluation of multiple image sequences simul-
taneously, providing clinicians with a tool to observe the malignancy extent concurrently in
Fundus and MRI. To do so, we combine the automatic eye segmentation for MRI presented
above with a manual segmentation of ocular tumors in Fundus. Then, we register these two
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image modalities with a novel landmark-based registration scheme and fuse the two imaging
modalities. We apply this new method to (i) improve the quality of the delineation in the MRI
and to (ii) use the back-projection scheme to transport rich volumetric measures from the MRI
to the Fundus, creating a new 3D shape representation of the 2D Fundus in a method that
we named Topographic Fundus Mapping. For all experiments and contribution, we validate
the results with a dataset of healthy and pathological eye MRIs and a dataset of pathological
Fundus images of retinoblastoma.
Keywords: Segmentation, Registre, Model specifique pour pacient, Machine Learning, Con-
volutional Neural Networks, Statistical Shape Modeling, Pattern recognition, classification,
Radiation Oncology, Pediatrics, Magnetic Resonance Imaging, Ophthalmolgy, Fundus Image
Photography
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Résumé
Le rétinoblastome et le mélanome uvéal sont les types de cancer oculaire les plus communs,
touchant les enfants et adultes respectivement, et peuvent se répandre à travers l’organisme
s’ils ne sont pas traités. Actuellement, le traitement pour la détection du rétinoblastome se
base essentiellement à partir de deux modalites d’imagerie fond d’œil (Fundus) et l’ultrason
(US). Cependant, d’autres modalités d’imagerie comme l’Imagerie par Résonance magnétique
(IRM) et la Tomodensitométrie (TDM) sont clé pour confirmer la possible expansion du cancer
en dehors de la cavité oculaire. Les techniques utilisées pour déterminer la tumeur oculaire,
ainsi que le choix du traitement, se basent sur des mesures multimodales réalisées de manière
manuelle par des médecins. Cette méthodologie manuelle est appliquée quotidiennement
et continuellement pendant toute la durée de la maladie. Ce processus nécessite souvent la
délinéation manuelle des structures ocularies et de la tumeur, un mécanisme laborieux et long,
effectuée dans des multiples séquences médicales simultanées (par exemple : T1-weighted et
T2-weighted IRM ...) qui augmentent la difficulté pour évaluer la maladie.
Le présent travail présente une nouvelle série de techniques permettant d’améliorer l´évaluation
multimodale de tumeurs oculaires en IRM et Fundus. Dans un premier temps, nous intro-
duisons une méthode qui assure la délinéation automatique de la structure oculaire et de la
tumeur dans un IRM 3D. Pour cela, nous présentons un Active Shape Model (ASM) construite
à partir d’un ensemble de données de patients en bonne santé pour prouver que la segmenta-
tion automatique de la structure oculaire (par exemple : le cristallin, l´humeur aqueuse, la
cornée et la sclère) peut être réalisée de manière précise et robuste. Afin de valider ces résultats,
nous introduisons un ensemble d’essais pour tester la performance du modèle par rapport à
des yeux de patients affectés pathologiquement par un rétinoblastome, et démontrons que
la segmentation de la structure oculaire d’un œil sain est possible, indépendamment de la
présence d’une tumeur à l’intérieur des yeux. De plus, nous proposons une caractérisation
spécifique du patient-specific eye features qui peuvent être utile pour la segmentation de l’œil
dans l’IRM 3D, fournissant des formes riches et une information importante concernant le
tissu pathologique noyé dans la structure oculaire de l’œil sain. Cette information est ultérieu-
rement utilisée pour entrainer un ensemble de classificateurs (Convolutional Neural Network
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(CNN), Random Forest, . . . ) qui réalise la segmentation automatique de tumeurs oculaires à
l’intérieur de l’œil.
En outre, nous explorons une nouvelle méthode pour évaluer des multitudes de séquences
d’images de manière simultanée, fournissant aux médecins un outil pour observer l’extension
de la tumeur dans le fond d’œil et l’IRM. Pour cela, nous combinons la segmentation auto-
matique de l’œil de l’IRM selon la description ci-dessus et nous proposons une delineation
manuelle de tumeurs oculaires dans le fond d’œil. Ensuite, nous recalons ces deux modalités
d’imagerie avec une nouvelle base de points de repère et nous réalisons la fusion des deux
modalités. Nous utilisons cette nouvelle méthode pour (i) améliorer la qualité de la délinéation
dans l’IRM et pour (ii) utiliser la projection arrière de la tumeur pour transporter de riches me-
sures volumétriques de l’IRM vers le fond d’œil, en créant une nouvelle forme 3D représentant
le fond d’œil 2D dans une méthode que nous appelons Topographic Fundus Mapping. Pour
tous les tests et contributions, nous validons les résultats avec une base de données d’IRM et
une base de données d’images pathologiques du fond d’œil de rétinoblastome.
Mots-clefs : Delineation d’image, Recalage, Patient-specific model, Machine Learning, Convo-
lutional Neural Networks, Model statistique de surface, Reconnaisance des Patrons, Classifica-
tion, Oncologie, Pediatrie, Imagerie Resonance Magnetique, Ophthalmolgie, Fond d’œil
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— Introduction
Ever since the beginning of egyptian civilization, one of the oldest known cultures dating back
circa 3.000 years before Christ (B.C.), society has venerated the Eye as the most important
sensorial organ – a symbol of omniscience and clairvoyance connecting the outside world with
the human psyche. Knowledge and interest for the eye has continuously evolved througout
thousands of years, shaping religion, culture and research to this day. For the biggest part of
this period, religion and cultural beliefs were drivers of common wisdom about vision, yet
research on the eye from an evolutive and clinical perspective remained minimal.
It was not until the second half ot 19th century that technical advances led to a breakthrough
in eye research. The official introduction of the ophthalmoscope, first reported in 1851 by
Hermann von Helmholtz [4], followed by other important creations such as the first proto-
types of the Fundus camera, developed in parallel by Henry Noyes and Abner Mulholland
Rosebrugh in the 1860s, became the first building blocks of modern medical eye imaging.
These inventions were not meant to be used in a clinical setup at that time (low quality images
and difficul image acquisitions without damaging the retina), however, thanks to these, J.D.
Webster invented the first human Fundus camera in 1886. Iterations followed over the idea
with Gerloff [5] until Gullstrand developed the first functional Fundus camera, a conceptual
model whose schematics are still used for imaging the interior of the eye [6]. The versatil-
ity and cost-effectiveness of the Fundus ophthalmoscope has proven its hegemony as the
modality of reference for imaging pathologies in the eye. Simultaneously, eye disease study
changed tremendously after the first retinal cameras appeared in 1926 [7]. The advances al-
lowed pathologies like ocular tumors, diabetic retinopathy, age-related macular degeneration
and others to be imaged for the first time. The development of such diseases could now be
observed via Fundus images as they mostly affect the posterior part of the eye, the so called
region of the retina, a densely populated multi-layer wall of photosensitive cells that captures
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light and transmits its representation of the environment to the brain. Furthermore, it is also a
highly vascularized region with a broad set of vessels providing continuous blood flow to the
cells located at the back of the eye. In ophthalmology, imaging of these vessels and layers on
a continuous basis with Fundus cameras remains the key diagnosis strategy for detecting a
large spectrum of ocular diseases.
During the same period that Fundus imaging was living its golden age, other techniques in
medical imaging were being developed (e.g. Ultrasound (US), MRI and Computed Tomography
(CT)). However, in spite of these new approaches becoming crucial for imaging pathologies
and deformations all over the body, their applicability in the eye remained far less significant.
The most important reasons for this were the aquoeus nature of the vitreous humor tissue,
conforming the biggest part of the eye ball, and also the small size of the organ to image,
directly affected by the limitations in image resolution and acquisition times. In addition,
the cost of these medical devices as compared to the simpler cost-effecive Fundus cameras
prevented any strong push towards changing the paradigm of eye screening procedures.
Technological advances have shifted this trend in the last 40 years, as methods and techniques
to speed-up acquisition time and improve image quality at 3-dimensional level have opened
the door to more complete diagnosis and capabilities, far beyond the 2D information of
Fundus. For example, 2D/3D US is a technique that has helped evaluating eye diseases such
as tumors and orbital conditions for the last 40 years. It came to light in the early 1920-30s as a
new method for therapy, however, it was not until 1940 when it was first used as a diagnostic
tool, and Karl Theodore Dussik the first official user of US in medical diagnosis [8]. Again,
systematic evolutions of the technology followed and it became a key imaging modality in
structural ophthalmology in the 70´s [9, 10]. Today, US is used to image vitreoretinal interface
disease and the anterior and posterior segments, allowing for a quick and easy exploration
of the VH cavity and pathologies that may be located therein [11]. For the specific case of
intra-ocular tumors, US is used for intra-operative screening and follow-up, being today one
of the medical imaging pillars for ocular diseases.
Recently, MRI and CT have also been used for imaging specific conditions in the eye, mostly for
screening ocular tumors. CT, developed in the late 60´s and introduced in the 70´s in clinical
setups, had been championed for structural image analysis of patient´s organs [12], however,
in the last period the use of CT for imaging eye tumors has been less and less recommended
[13]. The reasons for this shift are twofold. On the one side, MRI scans can now have an image
resolution similar to that offered by CT, while providing a more rich representation of different
tissues. Second, medicine is slowly evolving towards non-ionizing techniques for patient
screening [14]. In this context, any method that offers similar results to CT without affecting
the patient´s health would be considered as an attractive path to follow. On the other side, the
negative effects of using CT on infants are far more agressive than in adults and, thus, it is no
longer recomended as a modality of reference for such diagnosis [15]. Alternatively, there is
MRI, a technology that has evolved intensively in the last 30 years and that has consistently
become more accessible for hospitals around the world. Today’s techniques have improved
traditional caveats such as the acquisition time and resolution, and these specific image
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modalities are now becoming the new standard for imaging ocular pathologies. In this thesis
we will dedicate some time to explore the principles of MRI and its potential for the future of
ocular tumors image analysis.
Finally, the last image modality to join medical imaging of the eye is OCT. The technology,
developed in the 90´s, became the first way to image in-vivo nanoscale tissue and has since
reshaped diagnosis and pathology detection for the leading causes of blindness worldwide.
OCT is a non-invasive light-sourced technique used to image materials by means of low-
coherence interferometry [1], reaching an unforeseen resolution of 10−10 meters. OCT and
all its wide variations has become the modality of reference for very early screening of AMD
and Diabetic Retinopathy Edema (DRE) [16–19], as well as a key for the research developed in
other fields (i.e. skin imaging, material science, ...). In the context of this thesis, OCT will be
briefly presented as the next frontier towards multi-modal patient specific eye modeling of
ocular tumors.
Figure 1 – Evolution of multimodal imaging in ophthalmology : From left to right, Fundus
image, Ultrasound, Computed Tomography, MRI (3T Scanner) and OCT scan. Past and present
of ophthalmology for retinoblastoma. The year on top corresponds to the year that the image
modality was first used to image the disease.
In summary, the last century has brought a bountiful set of imaging modalities to science,
reshaping clinicians work and decision making process before treatment and during follow-up
(see Fig. 1 for more information). The birth of modern imaging in the late 19th century has
resulted in several science fields being created. One of these is medical imaging, covering
not only the research related to the representation of organs and tissue, but also devoted to
comprehend and leveraging information accross sources, all towards improving healthcare.
In this context, medical imaging analysis tries to answer questions and to find solutions to
challenges in subfields such as the registration, the segmentation, the reconstruction, the
super-resolution and the statistical modeling of images or volumes. Some of these topics
are very present in ophthalmology for the analysis and detection of the most common eye
diseases. However, while these techniques are used for specific eye pathology screening
independently, there are particular contexts in which both medical imaging at the macro
and the micro-scale need to be combined together. The context of ocular tumors is such a
case. Unfortunately to date, the topic of ocular tumor medical imaging has not been widely
covered in the literature from a technological point of view, both for retinoblastoma and uveal
melanoma, two important types of ocular tumors. In the clinical context, however, radiologist
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have provided a multitude of essays with extensive reviews for assessing the evaluation of
treatment strategies and the outcome of such experiments, focusing more on the clinical
contributions than on the development of new techniques for treating eye malignancies. The
reason for this is that ocular tumors are an uncommon disease, and even when they have
been imaged consistently via Fundus and 2D US for the last decades, there are still plenty of
challenges and unknowns which lend themselves for scientific investigation.
To this end, this thesis will explore how to overcome some of the most important medical
imaging challenges in ocular tumors in MRI, such as the time consuming tasks of delineation
and detection of pathologies, and how to leverage current medical imaging techniques to
propose tools to standardize clinician´s support, improving the treatment strategies for eye
cancers. Furthermore, we will propose new methods to extract contextual information from
the already available image modalities based on medical image analysis techniques (e.g. MRI
and Fundus), supporting clinicians with accurate patient-specific information and helping
them whenever repetitive and tedious tasks arise.
Thesis Statement
Multi-modal fusion using segmentation of the eye structures and pathologies support clinicians,
ophthalmologist and radiologist to better characterize ocular tumors simultaneously, and
provides the basis required for precision medicine during ocular follow-up and before treatment.
Thesis Outline and contributions
This work introduces a first attempt to combine and characterize multiple image modalities
required for proper treatment and diagnosis of ocular tumors, with a particular emphasys on
the automatization, precision and accuracy in the image processing techniques to achieve
these goals.
Thesis Outline
• Chapter 1 introduces the necessary background to understand the contributions of this
work. We present a brief description of the eye anatomy and specifically, develop on eye
diseases and ocular tumors. We explore current eye imaging techniques and provide
an overview of the procedures we utilize for performing the automatic detection and
delineation of ocular organs and tumors in multiple image modalities. To conclude we
study the methods that allow multi-modal fusion of different images modalities.
• Chapter 2 focuses on the automatic segmentation of eye structures in 3D MRI, towards
improving retinoblastoma diagnosis and treatment. Here, we utilize ASMs for modeling
a set of anatomical shapes in healthy eyes, defining a Healthy Model (HM) for the
strucures of the lens, the sclera, the cornea and the vitreous humor. This work introduces
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the first automatic segmentation framework to automatically delineate the eye in 24
healthy children eyes.
• Chapter 3 continues the previous work and studies a new method for the automatic
delineation of ocular tumors and structures in multi-sequence MRI ( e.g. T1w VIBE and
T2w). We will refer to this model as Pathological Eye Model (PEM). We also introduce
a set of Eye Patient-specific Features that support the segmentation procedure with
rich voxel-level spatial and intensity information, improving the segmentation results
consistently.
• Chapter 4 directs the attention towards the segmentation of retinoblastoma in Fundus
and introduces the multi-modal fusion of MRI and Fundus. This section covers a set of
techniques for achieving landmark-based registration from 2D Fundus to 3D MRI.
• Chapter 5 introduces two different applications for the multi-modal fusion of MRI and
Fundus. The first one is improving the automatic segmentation of ocular tumors in the
3D MRI via Fundus imaging, the second contribution is the introduction of Topographic
Fundus Mapping, a new method for the evaluation of Fundus images based on rich 3D
MRI information.
• Chapter 6 draws the general conclusions and provides an overview of the work devel-
oped during this PhD, introducing future development lines.
• Annex A expands the methods developed in chapter 2, towards achieving automatic
segmentation of eye structures in the MRI.
• Annex B introduces the Eye Modeler software, a medical image analysis tool written in
C++ and developed for supporting clinicians during the evaluating of medical images of
the in eye (Fundus, MRI, CT, ...).
Thesis Contributions
The contributions of this work can be summarized as :
• A new framework for the fully automatic segmentation of the eye in MRI by means of an
ASM for the regions of the sclera, the cornea, the vitreous humor and the lens in T1w
VIBE. This ASM will is referred to as HM. We furthermore create a PEM of the eye, built
out of 32 pathological patient eyes, and compare the results with the HM presented in
[2]. Prior to this, a preliminary work was presented in the American Research in Vision
and Ophthalmology 2014 conference (ARVO), Orlando, United States [20].
• We introduce the Eye Patient-specific Features (EPSF) , derived from our segmentation
with the pathological ASM, which helps characterize pathological tissue by providing
rich local and global information, even when only small amounts of training data is
available. We use these EPSF to build a novel automatic segmentation framework
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tailored to ocular tumors. This framework uses of a Markov Random Field (MRF) to
represent the presence of healthy and pathological tissue. We encode prior information
of the tumors by means of an ASM, as an alternative to the use of typical brain atlas
priors or existing ASMs of healthy eyes. This work is currently under review in the Plos
One journal [21].
• We propose a new method for the automatic fusion of Fundus and MRI by registering
common anatomical landmarks present in both image modalities. We furthermore
test our approach on two different applications: a) We use the multi-modal 2D to 3D
Fundus Prior in order to improve the quality of the segmentation in MRI and b) We use
the multi-modal fusion in order to transfer rich 3D volumetric information into the 2D
Fundus image, in a process that we called Topographic Fundus Mapping (TFM). This
work is currently under preparation to be submitted to the IEEE Transactions on Medical
Imaging journal [22].
• To conclude, we present a new software tool called Eye Modeler that allows the user
to load imaging data (MRI, Fundus, . . . ), annotate information relevant to the patient,
build ASMs out of manual delineations of patient eye structures and to do the automatic
segmentation of the eye in 3D MRI. The goal of this tool is to support clinicians before
treatment and for follow-up of ocular tumors.
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Background
Human Eye Anatomy
The eye is a key organ in constant evolution and is often regarded as the miracle of nature
design [23]. Evolving from single cells to become one of the most valuable animals senses
during the Cambrian evolution ≈ 540 million years ago, the cells that now form the eyes
followed a transition that started with the task of measuring light sensitivity to today´s focus
on locomotion and navigation by vision.
Leaving aside the particularities that created this masterpiece, this section will explore the
anatomy of the human eye and certain functionalities related to it. We start by providing an
overview of the different parts that comprise the eye ball and their relevance in vision, and
continue with a specific explanation of common ocular pathologies and ocular tumors, the
latter being the central topic of analysis in this thesis.
Anterior Eye Segment
The human eye can be divided into two sections, the posterior and the anterior segment
(see Fig. 1.1). The Anterior Segment (AS) comprises the structures in front of the eye: the
cornea, the iris, the ciliary body and the crystalline lens. It is itself divided into two additional
chambers, called anterior and posterior chamber. The Anterior Chamber (AC) is a cavity filled
with the aqueous humor (a transparent fluid inside the eye), and between the iris and the
cornea that allows vision. It is also a key mechanical part of the eye, and it is responsible for
focusing the light that will later go to the ocular chamber. From a pathology point of view,
the AC is linked to pathologies such as glaucoma, that we will introduce briefly later on in
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Figure 1.1 – Eye Diagram : Representation of the human eye indicating the anterior and
posterior segment. The regions of the cornea, the lens, the vitreous humor, the sclera, the
fovea, the optic disc, the optic nerve and the retina are highlighted. Source: Shutterstock -
Alexilusmedical ©.
section 1. For completion, the Posterior Chamber (PC) is located on the surroundings of the
iris, just in front of the ligaments (zonules) that control the lens concavity and the VH.
The AS is as well in charge of linking the external world and the visual processing system in
the Posterior Segment (PS), whilst protecting the whole outside with a thin transparent layer
of collagen fibers known as the cornea. The remaining of the anterior segment in formed by a
series of mussels and fibers (ciliary body, ciliary muscles and zonules) that support a central
opening systems known as pupil, controlling the amount of light that goes into the retina. A
more detailed representation of the eye can be seen in Fig. 1.1.
Posterior Eye Segment
The PS contains the region of the eyes in charge of capturing visual information using pho-
tosensitive cells. It starts with the anterior hyaloid membrane and continues with the VH,
the retina, the choroid and the optic nerve (see Fig.1.1). Within the PS, we identify a region
connecting the AS and the PS called uvea, comprising the choroid, the ciliary body and the
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iris. This particular region is where uveal melanoma takes root [24].
One of the most critical parts of the ocular system is that formed by the different retinal layers,
a set of multiple thin coating covers that perform the task of transforming light from the
early layers into signals transmitted via the optic nerver towards the brain. An interesting
representation of the process transforming the light into impulses cell after cell is that of the
Spanish researcher and Nobel Laureate Santiago Ramon y Cajal back in 1911 Fig. 1.2-A).
Figure 1.2 – Diagram of human retina : A) Retinal layers as drawn by Ramon y Cajal in
1911. Despite not having a high resolution microscope, the Spanish researcher was able to
create a very accurate representation of the various eye cells. B) Diagram of the human retina
connected to and histopathological section of the retinal wall.
Also relevant to this work is to provide a brief explanation of the shape and growing pattern
of the human eye, ranging from an initial size of 16-17 mm diameter when humans are born,
and reaching 22-25 mm at the adult age. Moreover, contrary to what it is often assumed, it is
not a complete spherical structure, but rather an oval-like organ.
Retina
The retina is the most complex region of the eyes and is composed of different types of cells
that work together to guarantee vision. From a functional point of view, the region focuses
on generating images by interpretation of signals from the light-excited rod and cone cells
(Fig. 1.2-B). The division between these two different types of cells is most significant when
considering the distribution of work. The rods, in the order of ≈ 100− 150 millions cells,
are very sensitive cells able to capture minor variations in light. Conversely, there are ≈ 7
million cone cells which provide sharp clear vision. Humans, together with many other
mammals, have a vascularized retina composed by a mosaic of vessels to nurture the eye
regions continuously. Despite the millions of years of evolution, this system has some flaws in
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its design. The most significant might be the existence of the OD, a ≈ 2mm radius disc that
serves as the connection of the retina to the blood flow and to the brain. This specific location
lacks photosentive cells and is considered as the visual blind spot. In practice, however,
mammals are not affected by this minor error in design, and the 3D stereo reconstruction
performed in the brain compensates for the missing blind spot information.
If we explore the eye a bit further in detail, humans have a location in the retina where most
of the cone cells are located. This region is know as the macula and provides humans with
acute vision. Also, the region comprised by the fovea coincides with the point of maximal
distance from the cornea tip, passing through the center of the lens and forming a direction
vector called Optical Axis (OA). Whenever humans with healthy vision focus their sight on an
object, the reflected light from that object is directed specifically to the center of the macular
region, to provide the best image definition. An example of the human retina with all the
aforementioned parts can be seen in Figure 1.3-A). If we take a step back to analyze the whole
retinal surface we will observe that sharp vision comprises a conic field of view of 60°, and is
centered in the macula, whilst the rest of the perimetral vision (comprising 200° for healthy
eyes) is distributed all over the rest of the eye. From a pathological point of view, the retina is
where most of ocular diseases take root (thus, the ever growing relevance in further studying
it). Retinal disorders such as AMD, diabetic eye diseases, retinal vein occlusion and retinal
detachments [17, 19] are all located in this region.
Figure 1.3 – Fundus image of the retina : A) Fundus of human retina, indicating the regions of
the macula, the fovea and the optic disc. B) Fundus of patient with an endophytic retinoblas-
toma tumor over the region of the macula.
In addition to all these pathologies with different prognosis and treatment strategies, the retina
is the area where ocular tumors are most frequently located (e.g. retinoblastoma in children,
Fig. 1.3-B). In the presented work we will base most of our contributions on applications for
better treatment of retinoblastoma.
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Eye Pathologies
The eyes are home to an extense range of vision diseases, varying in severity and origin. In
this section we will provide a short overview about the most common ocular pathologies in
the region of the retina (AMD, DR) and glaucoma), and an extensive overview about ocular
tumors, more specifically, retinoblastoma.
Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR)
The leading cause for vision loss among elderly people over 50 y.o. worldwide is AMD[19].
AMD causes a gradual degeneration of the macular region of the retina (that is, the area
surrounding the fovea, see Fig. 1.4). The malignancy typically evolves slowly at the early stage
and can often pass unnoticed due to early symptoms being mild. As the disease progresses,
there is a gradual loss of central vision, complicating every day activities. Unfortunately, to
date there is no cure yet and only certain sources of medication can help slowing down the
evolution (e.g. anti-Vascular Endotelial Groth Factor (VEGF) drugs, laser coagulation treatment
or photodynamic theraphy). Regarding the risk factor and diagnosis, AMD mostly affect elderly
people and individuals with a family history related to the disease, however, individuals factors
like smoking, hypertension, artherosclerosis or obesity have proven to increase the chances of
suffering from AMD and vision loss. Today diagnosis is mostly performed by exploring the
interior of the eye with a) Fundus cameras, which work very well in the detection of dry macular
degeneration by detecting drusen in the retinal wall [25], b) fluorescein angiography, to detect
leakage in the vascularization behind the macula, known as wet macular degeneration, one of
the few conditions that allows for treatment of the disease, and c) OCT, used mostly for the
confirmation of the pathology and for patient follow-up [16].
DR, on the contrary, is a disease affecting the vascularization of the retina in diabetic patients.
Even if the disease eventually leads to the blindness, there is a good opportunity for it to remain
under control, mainly when proper monitoring is conducted. One of the biggest problems
linked with DR are the lack of symptoms, thus, it is difficult to detect at the early stage. Current
methods for the detection of the disease consist on the early evaluation of diabetic patients
via Fundus imaging, toward detecting Non-Proliferative Diabetic Retinopathy (NPDR) of later
stages of DR or the use of OCT for accurate pathology detection [26]. Among the different risk
factors, we highlight the time the patients has suffered from diabetes disease and the type.
Type I and > 60% of Type II diabetes will experience some level of DR in their lifetime. One
of the most relevant factors to consider about DR is that early detection allows for proper
treatment and a major part of patient’s vision can be preserved (e.g. Laser photocoagulation,
anti-VEGF drugs and more).
An example of the effects caused by both AMD and DR in vision can be observed in Fig. 1.4-B-
C).
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Figure 1.4 – Effects of AMD, DR and Glaucoma in vision : These pictures show the results of
suffering from B) Age-related Macular Degeneration (AMD) and C) Diabetic Retinopathy (DR)
and D) Glaucoma. If left untreated all three diseases will outcome in the complete loss of
vision for the patient. In image A) we can observe the original image without vision distortion.
Ocular tumors, such as retinoblastoma, show similar image distortion conditions depending
on the location of the tumor and its size.
Glaucoma
Glaucoma is a disease that covers a broad set of pathologies affecting vision and the optic
nerve. The malignancy normally starts with a reduction of the peripheral vision and continues
to affect the central vision (macular region) gradually [27]. Different symptoms consider eye
pain, eye redness or blurred vision, eventually leading to blindness if the patient is not properly
treated. Among the most common risk factors for the development of the disease we find high
eye pressure, obesity and a family history of glaucoma [28]. Current methods for detecting
glaucoma consider the evaluation via Fundus and OCT, as well a visual test examination for
assessing vision quality. Indicators such as the cup-to-disc ratio also provide information
about possible damage due to the appearance of glaucoma [29]. One of the good news about
glaucoma disease is that laser treatments, medication and surgery can reduce the eye pressure
and possibly stop or reduce the evolution of the disease [30]. An example of the effects in
vision caused by Glaucoma can be seen in Fig. 1.4-D).
Ocular tumors
Retinoblastoma and uveal melanoma are the most common eye tumors in children and adults
[31, 32]. In this thesis we will focus our efforts in the former, though most of the techniques
and contributions we introduced could be easily translated to adults.
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Retinoblastoma
Retinoblastoma is a fast spreading eye tumor appearing in children before the age of five
[31, 33, 34]. It normally takes root in the posterior part of the eye and develops towards
the rest of the body if left untreated [35]. The disease is related to high levels of mortality
and morbidity, thus, early detection is key for maximizing chances of proper treatment and
recovery. Clinicians often suggest that children´s life is out of danger if the tumor is kept
inside the ocular cavity [36], however, the risk is strongly linked to the size of the tumor
and its growing pattern. Research studies have shown that retinoblastoma is very often an
hereditary mutation (≈ 50%), affecting the RB-1 gene, localized in the chromosome 13q14
[37]. For the rest of cases, the origin of the pathology is a congenital mutation in the same
gene. One of the particularities of these malignancies is that they can affect one or both eyes
(uni- or bilateral retinoblastoma), depending on inheritance factors, however, the occurence
of bilateral retinoblastoma is mostly found in patients which have a family history related to
the disease. Furthermore, this last subset is prone to be affected by a more aggresive form of
cancers, such as pineoblastomas and Primitive Neuroectodermal Tumors (PNET), these rare
cancer forms may appear in combination with retinoblastoma in a more aggressive mutation
known as trilateral retinoblastoma. Unfortunately, the chances of survival for patients with
such form of retinoblastoma are low [38].
Among the risk factors for metastasis and tumor recurrence, the spread of the tumor via
the eye wall (sclera and choroid) into the orbit, or the spread of the disease via the optic
nerve are unwanted and often jeopardize patient survival [39]. Furthermore, patients have
shown a higher risk for developing secondary malignancies throughout time after treatment
with ionizing techniques [40], therefore, it is highly recommended to keep their exposure
to radiation levels low and, even during treatment, to keep a good balance between risks
and benefits of imaging and treatment strategies. A clear example is that of CT, a modality
whose controversial use in imaging these patients has shown a theoretical increased risk of
developing secondary malignancies due to the RB-1 gene mutation.
Despite retinoblastoma being a very aggressive tumor, low indicidence rates in the order
of 1 every 17.000 newborns [37] suggest that no mandatory revision is required in babies,
unless there exist a given family record. Early eye examinations are though recommended,
including red reflex and Hirschberg tests for detecting early retinoblastomas in children, and
the appearance of leukocoria [41] is a strong indicator of the presence of abnormal tissue
inside the eye.
Concerning the tumor growth pattern and behavior, retinoblastoma is divided in four different
groups: endophytics, exophytic, a combination of endo- and exophytic and, in very rare cases,
diffuse infiltrating tumors [39]. The difference between endophytics and exophytics relies on
whether they develop in the intraretinal layers or outside them. For the rare cases of diffuse
infiltrating tumors, the situation appears when multiple patches appear in different locations
in the retina, without a clear cancer mass.
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Figure 1.5 – Different types of retinoblastoma tumor in MRI : These pictures show an A)
Endophytic retinoblastoma, B) Exophytic retinoblastoma and a C) patient with a combination
of Endo- and Exophytic retinoblastoma (as well as a partial retinal detachment due to the
tumor presence).
Table 1.1 – International classification of retinoblastoma (ICRB) : Reference guide based on
specific tumor features to support treatment strategies and follow up [3].
Group Quick Reference Specific Features
A Small Tumor Rb <3 mm in size
B Large Tumor Rb >3 mm in size or
macular Rb location [< 3mm to foveola]
juxtapapillary Rb location [ ≤ 1.5mm to disc]
clear subretinal fluid ≤ 3mm from margin
C Focal Seeds Rb with
subretinal seeds ≤ 3mm from Rb
vitreous seeds ≤ 3mm from Rb
both subretinal and vitreous seeds ≤ 3mm from Rb
D Diffuse seeds Rb with
subretinal seeds > 3mm from Rb
vitreous seeds > 3mm from Rb
both subretinal and vitreous seeds > 3mm from Rb
E Extensive Rb Extensive Rb occupying > 50% globe or
Neovascular glaucoma
Opaque media from hemorrhage in anterior chamber, vitreous or subretinal space
Invasion of postlaminar optic nerve, choroid (> 2mm), sclera, orbit, anterior chamber
Treatment of ocular tumors
Treatment of ocular tumors depends mostly on the size, location and spread of the disease.
For the case of adult uveal melanoma patients, treatment follows a pathway where repetitive
invasive surgeries and ionizing radiation are regularly considered [42]. For the specific case of
retinoblastoma, the aim is always to explore less invasive treatment strategies and to proceed
to more radical techniques only if the pathology does not evolve positively. In this context,
and in order to support the process of decision making, an International Classification of
retinoblastoma (ICBR) table was introduced to standardize the evaluation process based on
features of interest [3] (Table 1.1).
From a treatment point of view, retinoblastoma is a disease that brings together clinicians
from several backgrounds (i.e ophthalmologists, radiologists, pathologists, ...) who play a
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role in the treatment, recovery and psychological support of the infant [3]. Keeping this in
perspective, the number of variables to consider are extensive and vary for every patient. In
here we provide a short description of the most common treatment strategies, including a few
words on the indicated tumor characterization for every case:
• Thermotheraphy suggests using infrared light to increase the tumor temperature to
45< °C. Very small tumors < 3mm may respond favorably to this treatment [31].
• Laser photocoagulation uses an argon or diode laser or a xenon arc in order to coagulate
all the blood supply to the tumor [43]. A few side effects include retinal detachments,
and retinal vascular occlusion.
• Cryotherapy induces the fast freezing of the tumor, with the side effect of damaging the
vascularization of the area of action. This therapy is generally very effective and arises
few complications[43], it is also recommended for tumors < 3mm.
• Brachytheraphy consist on placing a radioactive implant (plaque) attached to the
outside of the eye ball. The idea behind is to irradiate the tumoral region with a dose
calculated based on the apex of the tumor inside the eye via transcleral diffusion. This
treatment is limited to tumors < 6mm [31].
• Intra-venous and intra-arterial Chemotherapy consists on infusing the patient with a
chemical agent directed to the tumor, towards shrinking its size. Chemotherapy alone
does not provide final results but allows for other less invasive therapies to be applied
[31, 36].
• Chemothermotheraphy is similar to the above, but including heat sessions (ther-
motherapy) directly inside the eye during a period of a month [44].
• Proton Therapy considers using a proton beam for treating patients with retinoblas-
toma. Protons cause smaller damage than x-rays, used in External Beam Radiother-
apy (EBRT), while providing the same level of radiation to the tumoral mass.
• EBRT is recommended for patients where chemotherapy did not provide positive results.
It consists on the irradiation of the tumoral area with a radiation beam. The chances
of causing second recurrent malignancies or cancers increases with this treatment are
relatively high [33].
• Enucleation is the last resort for critical stage retinoblastoma patients, consisting in
the removal of the eye. This solution is reserved for an advanced disease that does not
respond to chemotherapy or any other of the previous techniques [43].
In Fig. 1.6 we show an overview of the different treatments strategies applied to the different
tumor sizes. As stated before, treatment of retinoblastoma evolves towards more aggressive
strategies if the cancer does not evolve positively.
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Uveal Melanoma
Figure 1.6 – Treatments strategies for retinoblastomas : Treatment strategies vary depending
on the size of the tumor, the location and the evolution. For most cases, Intra-arterial / Intra-
vitreal chemotherapy is applied in combination with other treatments to reduce the tumor size.
In this diagram, treatment evolves from left (mild treatment) to right (aggressive treatment).
Uveal Melanoma
Uveal melanoma is a disease that takes root in the region of the uvea, composed by the choroid,
the iris and the ciliary body [45]. The cancer arises from the pigment cells giving color to the
eyes (melanocytes) and affects mostly to the adult population over the age of 60 years. Uveal
melanoma is divided into different types of tumors depending on the location, being the AS a
more favorable location than the PS for patient recovery. That is, tumors located in the region
of the choroid will experience a least favorable prognosis as compared to the tumors located
in the region of the iris, being the latter far less common and difficult to detect [46].
As regards to the symptoms, uveal melanomas are not easy to discover in early stages of the
disease. They generally become visible once the tumor enlarges, either because they distort
the pupil (in the case of iris melanoma), due to a blurred vision (ciliary body) or due to a loss
in the visual acuity, as a result of potential retinal detachments. To date, US evaluation by
clinicians remains the main method to detect the malignancy, however, other techniques such
as CT and more recently OCT are being used to take decisions for future treatment and for
therapy planning. The risk factors for developing this type of tumors considers the iris color,
the skin color and the ability to tan, specially for the caucasic Europeans, as the most relevant
factors for the appearance of the disease [47].
In a similar fashion to retinoblastoma, there are a complete set of options to consider in order
to prevent the tumor spread. For small tumors, treatments such as thermotheraphy, photoco-
agulation and photodynamic therapy are utilized, however, there is a certain controversy as
to their effectivity [48]. For bigger tumors though, the roadmap is a bit more agressive than
that of retinoblastoma patients, with a transition between brachytherapy and external beam
radiotherapy happening in the last 10 years. Latest advances in medical imaging have pushed
the use of MRI and CT for 3D tumor planning before therapy, with medical image analysis
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tools such as OCTOPUS [49] being used prior to the procedure with favorable results. Today,
patients with uveal melanoma with a size over > 3mm will most likely undergo treatment
considering EBRT, opting for enucleation if the treatment is not effective.
In this thesis we will focus our efforts in the evaluation of techniques and methods for improv-
ing intra-ocular tumor treatment planning of retinoblastoma. Most of the techniques applied
here could be easily ported to uveal melanoma treatment in adults. For more information
about uveal melanoma, we would like to direct the reader to the following literature [24, 32, 46].
Eye Imaging Techniques
Diagnosis of eye pathologies is generally established on the basis of Fundus and 2D US
evaluation. Ophthalmologist have traditionally scanned the eye with rather simple, yet useful,
imaging techniques that allow for the screening of the most critical parts of the eye. For more
advanced pathology screening where structural information is required, the use of CT and
MRI, for adults and children respectively, is common. Nevertheless, due to the high cost
related to these image modalities and because of their use, mostly related to imaging ocular
tumors, it is rarely necessary. In the last years, though, OCT is gaining more and more traction
in the field of retinal pathology observation. This situation is mainly driven by the constant
improvements in the hardware technology behind OCT and also thanks to medical image
processing techniques, that allow the visualization of micrometric tissue structures.
For the remainder of this section we will focus on the image modalities that are used in this
thesis, 3D MRI and Fundus, and briefly explain why CT is no longer recommended, following
a short introduction about the future of retinoblastoma imaging in OCT. The motivations that
supported the focus on these two techniques are related both to (i ) the protocol for imaging
eye cancers, which is more and more reducing CT for treatment planning of ocular tumors in
children (retinoblastoma [14]) and (i i ) the data acquisition constraints. For the pathologies
studied here, US-acquired images were not providing the 3-dimensional information required
to evaluate the tumor extent, thus MRI was necessary to look for calcifications and possible
invasions of the optic nerve.
Fundus Imaging
Fundus imaging is the process whereby 2D representation of the 3D retinal tissues are acquired.
To capture those, doctors may project light inside the eye by means of a Fundus camera and
acquire the reflecting light from the eye again through the eye lens [50]. There are a few
different imaging techniques that fall within the cathegory of Fundus imaging : simple Fundus
Photography (also called red-free photography), Color Fundus Photography, Stereo Fundus
photography, Hyperspectral Eye photography, Scanning Laser ophtahlmoscopy (SLO) and
adaptative optics SLO and Angiography [50].
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Fundus Imaging
Overall, Fundus cameras aim to obtain a 2D representation of the retina, including the re-
gions of the macula and the OD. In a nutshell, they could be represented as a small form of
microscope (with an attached flashing camera at the tip) to acquire images of the eye. A more
detailed representation of the working principles of Fundus can be found in Fig. 1.7. Clinicians
typically place the patient sitting in front of the device, with the chin resting on a holder and
the forehead laying against the device (see Fig. 1.8-A). The ophthalmologist then proceeds
to focus the image and take a picture. For the specific case of children with retinoblastoma,
the process often includes a mobile Fundus camera, specific for pediatric imaging, as seen in
Fig. 1.8-B).
Figure 1.7 – Fundus camera working principle : Fundus camera working principles. The light
source enters the eye from a lateral source illuminating the retina. A combination of lens
allows the acquisition of the projected light into into the photosensitive sensor.
In the context of pathology screening, it is mainly used for observing AMD, DR and glau-
coma. In Fig. 1.9-B-C) we can observe a few examples of the pathologies and the Fundus
representations connected to these specific disease.
Figure 1.8 – Fundus cameras : A) Zeiss Fundus camera with a holder for resting the chin.
B) Detail of Pediatric RetCam. A set of interchangeable lens simplifies the procedure by the
clinician.
Also, Fundus is the key image modality for the follow-up and early diagnosis of retinoblastoma
and uveal melanoma [33, 36, 37]. Despite Fundus having the key role in the evaluation of the
disease, still it requires confirmation from completementary image modalities, such as US or
MRI. In Fig. 1.9-D) we can see a few example of Fundus images of retinoblastoma patients.
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Figure 1.9 – Fundus images for different pathologies : A) shows the picture of a healthy
Fundus, B) Diabetic Retinopathy, C) Age-related Macular degeneration and D) retinoblastoma.
Limitations
While these 150 years of development have served very well to improve the current Fundus
imaging systems, there are still a few challenges to overcome. Among the major limitations
that affect Fundus we may highlight the difficulties to generate a proper 3D representation of
the retinal wall [50], the difficulties related to observing pathological volumetric information
in the retina (e.g. tumors) and the skills that ophthalmologists require in order to acquire
proper Fundus images. Also, minor limitations such as the light that the delicate retina can
whitstand and the optics system building the eye (lens, acqueous regions ...) are important
factors affecting the image quality.
At a more pathology specific perspective, there exist a number of limitations affecting Fundus
imaging of ocular tumors. As observed in Fig. 1.9, big tumors in the interior of the eye do not
allow for a proper imaging of the disease and alternative image modalities are required. It is
also true that whenever such tumors are encountered, the disease is certainly in an advanced
stage and very few possible treatment solutions are available (EBRT or enucleation).
To conclude, limitations such as the cost of the device may be crucial in countries where
access to medicine is not trivial. In this direction, latest technological advances such as the
one proposed in the last years to integrate Fundus acquisitions on mobile phones are opening
the door to a widespread use of Fundus screening by populations at risk.
Ocular Magnetic Resonance Imaging (MRI)
MRI acquisition has been one of the pillars of medical imaging ever since its conception in 1973
and is today an indispensable tool for structural medical diagnosis. It is also a non-invasive
non-ionizing image modality which provides similar structural information as compared to
CT, and goes beyond this image modality by providing tissue information, key to the evalution
of certain pathologies. The working principle of MRI is a complex combinations of equations
and tecnology developed throughout more than 40 years [51].
It all starts with a directional magnetic field which traverses the body and alters the hydrogen
proton nuclei (an element present in water and body fat in high amounts). The spinning
hydrogen proton has a north and south pole distribution, which is affected by the action of
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the magnetic field, inducing those protons to align with the magnetic vector created inside
the scanner. Now, an additional electromagnetic Radio-Frequency (RaFr) pulse (known as the
Lamor frequency) is added to the magnetic field, creating a deflection that will cause certain
hydrogen proton nuclei to resonate and to modify their spin with a strength proportional to
the magnetic field inside the scanner. This procedure is known as excitation. The strength of
the magnetic field can be altered locally at different possitions inside the scanner, thus making
it possible to acquire different slices of the body therein.
Once this process is finished, the RaFr wave stops and the protons return to their original
resting states, emitting a RaFr pulse during the process. This signal is recorded by the MRI
scanner thanks to a set of receiver coils and has the shape of an exponential curve. Sampling
of this curve generates the so called k-space, which is nothing more than the representation of
the image in the frequential domain (Fourier). 2D/3D scans are the cumulative mapping of
specific locations in the volume with a varying time and excitation, representing this specific
tissue in space. The reconstruction of image is achieved by computing the inverse fourier
transform of the k-space volume, as seen in Fig. 1.10
MRI for imaging Ocular Tumors
MRI has a very diverse set of acquisition techniques which show different non-complementary
sources of information about the patient. Among the most relevant sequences for imaging
ocular cancers we find 2D/3D T1w-VIBE and 2D/3D T2w [37], all of them used in order to
explore the appearance of trilateral retinoblastoma, invasion of the optic nerve and extraocular
tumor spread [39]. For the specific application presented in this thesis we focused on the
evaluation of 3D T1w-VIBE and 3D T2w.
T1w-VIBE is a Gradient Echo (GE) sequence whose data acquisition process can be easily
reformatted to provide volumes in different orientations, a procedure often called multiplanar
reconstruction [52]. Furthermore, it is often the case that patients are injected with an intra-
venous contrast enhancer, a solution to improve the imaging conditions of the tumoral region
during the scan. These image modalities are typically part of the routine imaging protocol in
our institution and facilitate the visualization of the tumor extent. An important insight about
the T1w VIBE used in this work is that they are fat-suppressed sequences, that is, tissue with a
higher concentration of fat will be represented with darker areas, as can be seen in Fig. 1.14.
Moreover, we also use 3D T2w. This specific sequence is commonly represented in conjunction
with T1w sequences and provides rich information about the presence of fluid in the imaged
area, resulting in higher signal intensities. Alternatively, low presence of fluid in the region
of interest is depicted with a lower intensity. Radiologist evaluate all these image modalities
concurrently for better diagnosis and treatment plan of the disease, independently of the
pathology.
As regards to the tumor presentation in the MRI, retinoblastoma often appears occupying an
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A) B)
C) D)
Figure 1.10 – Details of MRI setup for children and example of MRI image in K-space : A-B)
General setup for patients with retinoblastoma. C-D) Detail of a T1w VIBE MRI and it k-space
representation.
area with a moderate high signal intensity on T1w and low signal intensity on T2w compared
to the VH [39]. Calcifications are also critical during MRI evaluations, and are spotted as areas
where intensity on T2w is low. All these sources of information are critical for decision making
and confirmation of tumor extent. A few examples of retinoblastoma tumors inside the eye
cavity can be seen in Fig. 1.14.
Limitations
Albeit the benefits of using MRI as a complementary source of information, or even an alter-
native to other image modalities such as CT, there are a few limitations to overcome. One of
the most important is the economic factors that are connected to these devices, making it a
really expensive tool for developing countries [53].
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Figure 1.11 – Retinoblastoma in MRI : Four examples of patients with retinoblastoma inside
the eye cavity. The size of the tumor and the spreading pattern may vary depending on location
and treatment.
In addition to the economic factors, MRI remains an structural image modality, and resolution
and acquisition time are an issue. Some of the pathologies that affect the ocular region are not
easily detected when evaluated solely on MRI. Additional evaluations with more established
image modalities, such as Fundus and US, are always required [31, 33, 37]. In-plane resolution
is also a limitation for detecting retinal detachments. Such cases can pass unnoticed due
to the resolution of the image, thus, screening the eye with non-isotropic sequences and in
different planes is a common protocol during acquisition.
Figure 1.12 – Limiting factors of MRI : A-C) Three MRI scans from different adult patients.
The region of the eyes is blurred due to the eye movement and saccades. Patients often need
to remain immobile during 3-5 minutes.
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Computed Tomography
CT is an image modality which combines x-ray scans taken from different angles in order
to produce a cross-sectional image of the body in 2D and 3D. The working principle of the
machine consists on the aggregation of these x-rays traversing the object of analysis and a
group of sensors capturing the attenuation caused by the living tissue absorption. CT is an
invasive medical image modality and is widely considered as an accepted alternative to the
costly MRI exploration for adults [15].
In the context of eye imaging, CT is mostly used for confirmation of tumor extent in pa-
tients with uveal melanoma and prior to treatment planning [42, 54]. For the specific case
of retinoblastoma, and due to the second malignancies related to imaging of newborns
[13, 14, 33, 55], it is no longer recommended as image modality of use for theraphy plan-
ning. Literature recognized CT as the first modality of choice to detect optic nerve invasion
and for detecting the tumor extent [56, 57], however, these conclusions appeared to be based
on conflicting outdated experiments, without thorough evidence by radiologic-pathologic
correlation studies, as stated in [37]. In this thesis we will focus exclusively on the study of 3D
MRI and Fundus, not only because of the data limitations, but also to follow the latest research
focusing on the use of these combined image modalities for evaluating ocular tumors [39, 55].
Optical Coherence Tomography (OCT)
OCT is a widespread non-invasive image modality for screening ocular pathologies starting
at micrometric resolution. The technology, which was first publish barely 20 years, ago has
evolved rapidly since its conception and now allows for a fairly easy screening of the layers
that conform the retina and the anterior segment. For the avid reader, an extended review
about OCT can be found in [1, 58].
The core working principle of OCT relies on low-coherence interferometry [1], using light
sources that generate extremely short pulses, such as superluminiscent diodes or femtosecond
lasers. This light in then divided into two beams, one containing the information that we want
to acquire and the other is used as reference beam. The combination of the scattering light
reflected from the sample and from the mirror that have traveled the same optical distance
provide an interference pattern specific to that given point in space. By performing this action
repeatedly accross the sample profile we can generate a vertical intensity profile called A-scan,
which can be agregatted in a cross-section of profiles called B-scans and combined in 3D
to generate the so called C-scan, as shown in Fig. 1.13. One of the particularities of OCT is
that it allows many different scanning patterns, including temporal and frequential domain
OCT [59, 60] and the possibility to scan the same region through time, in a specific manner
called M-scan. Research in the area of OCT analysis and development is bountiful [18, 60, 61]
and new frontiers such as full eye OCT including the anterior and posterior segment are closer
everyday.
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Figure 1.13 – Evolution of OCT imaging : Two pictures showing the evolution of OCT in the
last 14 years. A) Shows the work presented by Huang et al. in 1991 [1] B) 3D C-scan acquired
from a Heidelberg Spectralis ® machine.
Traditional OCT systems require patient cooperation during acquisition, thus, it is not quite
adapted for the use in children with retinoblastoma [62]. The solution in the last years has been
the introduction of hand-held intraoperative devices that solve this cooperation problems
and allow for the screening of ocular tumors. Current protocols for screening do not rely
much in OCT yet, mostly due to the nature and size of the tumor, however, further advances
in the characterization of the cancer tissue would outcome in interesting studies about the
pathology and the genetic factors that play a role in development of ocular tumors.
Medical Image analysis
Evolution of medical image analysis in the last forty years has been exponential. Since the ex-
plosion of general purpose computers in the 80´s, the distribution of devices for acquiring and
processing medical images has grown together with computational power and its translational
application a multitude of fields. The tools and knowledge that were required to compute
the first complex 3D reconstruction of MRI and CT signals would not be a reality without
the symbiotic link between fields, resulting in a community of researchers able to study the
structure, the functions and the pathology of the human body via images. Today, medical
image is composed of a complete set of pillars, including image segmentation, quantification,
registration, enhancement and visualization, each of them comprising a populated field of
research by itself. In this thesis we will focus specificilly on two fields, the statistical modeling
field towards image segmentation and the machine learning field for image classification. For
the avid reader, we would refer to the complete work in [63] for more information.
Image Segmentation
Segmentation is the process whereby we delineate a certain Region of Interest (ROI) in a
medical image. This task is particularly important when it comes to characterizing regions
in datasets of medical images, such as to indicate location and shape of organs, tumors or
malignancies, towards further studying and analyzing the contoured region.
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Research in this field has been very fruitful, and different ways to perform dataset labeling
have been proposed. In the context of this work we will focus our efforts on the automatic
segmentation of differents regions in the eyes, as well as the segmentation of pathological
areas (see Fig. 1.14). This last contribution is important because it helps ophthalmologists
and other clinicians to take decisions on treatment strategies (e.g. by looking at the size of the
tumor) as well as to measure the evolution of the shape through time during follow-up. For
completeness, we would direct the reader to the following works for an extensive reading in
the field of image segmentation [64, 65].
Figure 1.14 – Segmentation of medical images in MRI : Example of segmentation of medical
images in 3D eye MRI. Manual delineation of the sclera, the cornea, the vitreous humor and
the lens of a retinoblastoma patient. The process of manual delineation of these images may
take between 2-3 hours.
Active Shape Models
For the first part of this thesis we will rely strongly on the theory of statistical modeling and
model based methods, and more specifically, on the combination of those via ASM. Statistical
models of shape are mathematical models that try to define the data-generating process out
of a given population of samples, approximating a probability distribution for this data. Model
based methods, on the contrary, make use of a prior model of what is expected to represent
the image and attempt to find the best match from the model to this new image [66]. To focus
the interest on the techniques of analysis applied in this thesis, we would like to address the
reader to [67, 68] for further literature on the topic.
In this work we utilize ASM, a subset of model based methods that learn patterns of variability
from a given population of annotated (segmented) images. These models learn the deforma-
tions inherent to the data and deforms exclusively in a way consistent to the data that was used
to train them, in contrast to other free deformation methods such as Active Contour models
[69]. The particularities of ASM as compared to different flexible models such as articulated
models [70, 71], active contours [69] or statisticals models of shape [72, 73] is that of allowing
this constrained deformation, especially tailored for human anatomy, where shapes look alike
in a big variety of cases.
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The working principle of ASM starts by selecting a set of points that represent the object shape,
a task which is performed for every example in the dataset. This set of representative points
should describe the shape as precisely as possible, and should not contain outliers. The so
called landmark points will contain the shape of the figure, relevant anatomic points (i.e the
center, details, ...) or the combination of both as to describe the shape in volume [67]. Once
these point are selected, the volumes are aligned in a common NCS, the reason for aligning
these is to study the statistics of the labeled point coordinates over the training set. From here,
the aim is to minimize the weighted sum of squared distances between equivalent points
accross shapes, thus, we iteratively modify the transformation matrix as to reach this goal [67].
Now the objective is to capture the statistics within the set of aligned shapes, for this, we need
to create a Point-Based Shape Variation Model (PBSVM) using the techniques explained in
[66, 67], that will encode the information representing the mean shape and the variation using
Principal Component Analysis (PCA) [74]. The information representing the shape will be
completely encoded into different modes of variation, which corresponds to the deformations
representative for the independently encoded variability of the data. A more detailed explana-
tion can be found in [66, 67] or in the Annex A of this thesis. In Fig. 1.15 we present an example
of the model shape for the three first modes of variation of the statistical model of the eye we
present in Chapter 2.
After the introduction of ASM, new approaches including Active Appearance Models (AAMs)
[75] and Constrained Local Models (CLMs) [76, 77] appeared, however, give the small amount
of data for training and the valuable results that were achieved with ASM we left the evaluation
of similar techniques for future work. In Chapter 2 we further develop the use of ASM as a
segmentation tool for different eye regions inside the 3D MRI.
Machine Learning in Medical Image Analysis
Machine Learning (ML) is the field of research that covers how to teach computers to perform
a task wihout being explicitly programmed for it, reshaping internal decision making process
based on the evaluation of data. Starting in the 50´s, after Alan Turing´s seminal work on Com-
puting Machines [78], this field has traditionally pushed researchers to ask questions about
similarities between humans and machines on how to solve human intelligence, however, de-
spite the effort, a solution to replicate human intelligence is not yet close. Nevertheless, in the
context of medical imaging, machine learning is key to succesfully tackle different challenges
such as image segmentation, registration and modality fusion. In this section we will briefly
introduce general ideas about machine learning applied to the context of classification and
regression for image segmentation and registration. For the avid reader, please refer to [79] or
[80, 81] for a complete revision about current machine learning theory and techniques.
The field of ML is typically divided into three categories, depending on the nature of the
problem they are tailored to solve: i) supervised learning, where the goal is to learn a decision
road map given an input and a solution output, ii) unsupervised learning, where the objective
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Figure 1.15 – Active Shape Model - Modes of variation : Model mean shape (x¯) indicating the
region of the sclera (upper left) and the vitreous humor and the lens (down left). First, second,
third and fourth (b1,b2,b3,b4) mode of variation and effects in shape deformation colored in
mm. wrt. the distance to the mean shape.
is to find a structure inherent to the data by analyzing solely the same input data and iii)
reinforcement learning, which consists in the continuous interaction with the environment
to receive an input that will allow the agent to achieve a certain goal. For the specific case of
medical imaging, the research is mostly focused on the fields of supervised and unsupervised
learning, and within it, we will focus on the task of classification.
Classification using ML techniques has been a very hot topic in the medical imaging commu-
nity in the last years [82]. Traditionally, clinicians are interested in the early diagnosis of the
pathology and in understanding the progression or severity of the disease. These two tasks
can be divided into classification and regression respectively. Furthermore, for the specific
case of segmentation, widely covered in this thesis in Chapters 2-3, the task can generally
be modeled as a classification problem, where a ML algorithm will learn how to distinguish
pathological from non-pathological tissue, or between different anatomical regions of interest.
Among the most important classifiers in the field of ML for image classification we highlight
Support Vector Machines (SVM) [83], RF [84], or Neural Networks (NNs) [85].
In the last couple of years, though, advances in computational power, the field of computer
vision (from which medical imaging has always received inspiration) and applications of
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Graphical Processing Unit (GPU) from video game industry have opened the door to more
advanced image processing techniques using CNNs. A CNN is a type of feed-forward NN in
which connections between different neurons are inspired by biological processes and Multi-
layer Perceptron (MLP) [86]. The particularity of this approach is that every neuron processes
a small portion of the image at a time, and tries to learn the features in their receptive field only
by looking at the whole training dataset. Furthermore, the use of convolutions has the goal of
reducing the number of parameters connecting every building block of the network. In this
thesis we will include an accurate description of the CNN techniques we used for segmentation
and classification as part of the methods in every chapter. Nevertheless, we recommend the
reader to visit [87–91] for getting more familiar with the field of Deep Learning (DL) and
advanced ML.
Fusion of multiple image modalities in Ophthalmology
To cover this last section of the background and literature, we will provide a short overview
of the different methods for fusion of multiple image modalities in ophthalmology, more
specifically, Fundus and MRI. As stated before in section 1, when it comes to imaging ocular
tumors, clinicians require to evaluate independent sources of data, and to decide treatment
based on multiple image modalities. For the specific case of retinoblastoma, the decision is
taken by the radiologist and the ophthalmologist, who may have different perspectives and
modalities of preference. Furthermore, the technique of choice comes with a series of implica-
tions, for instance, for the case of MRI, even though it enables volumetric characterization and
detection of calcifications (an information that cannot be seen in Fundus) still sensitivity is
not enough as to be the sole image decision driver, and other modalities are required (i.e US).
Alternatively, for the case of vitreous and subretinal seeding and detachment, tumor seeding
can often be seen in Fundus, but not in MRI [92, 93].
The literature in the field of fusion is not very broad and only the work by De Zanet et al. [94]
attempts to combine those image modalities, paving the way for a combination of macro
structural data, in the order of milimiters, with microstructural data, with a scale in microme-
ters. Unfortunately, in the context of ocular tumors, data is scarce, and proper multi-modal
imaging of such patients is an endeavor difficult to pursue. In this thesis, we will explore what
we believe is the first attempt to achieve multi-modal fusion of pathological MRI and Fundus
in chapters 4 and 5.
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Automatic Segmentation of the Eye in
3D MRI: A novel Statistical Shape
Model for treatment planning of
Retinoblastoma
The work presented in this chapter was originally published as C. Ciller, S. I. De Zanet, M.B.
Rüegsegger, A. Pica, R. Sznitman, J-P. Thiran, P. Maeder, F. L. Munier, J. H. Kowal, M. B. Cuadra
“Automatic Segmentation of the Eye in 3D MRI: A novel Statistical Shape Model for treat-
ment planning of Retinoblastoma”, Internation Journal of Radiation Oncololgy Biology
Physics 2015 (92)4 , pp. 794-802, 2015. A 1-page peer-reviewed conference abstract and
poster were originally presented at s C. Ciller, S. I. De Zanet, A. Pica, J-P. Thiran, P. Maeder, F. L.
Munier, J. H. Kowal, M. B. Cuadra, “Automatic magnetic resonance imaging segmentation of
the eye based on 3D Active Shape Models”, Investigative Ophthalmology & Visual Science,
2014 (55)13, pp. 5848-5848.
2.1 Introduction
Retinoblastoma is the most common form of intraocular tumor in children and affects roughly
one in every 18.000 newborns worldwide [31, 95]. With 90% of cases identified by the age of
three, most retinoblastomas are curable, especially when the tumor is confined to the area
between the retina and the surface of the VH [37]. For this reason, accurate and non-invasive
techniques that can be used for early diagnosis assessment and the tumor extent follow-up or
treatment planning are critical.
Today, Fundus image photography and 2D US are the key image modalities of choice for the
diagnosis and follow-up of intraocular tumors [33]. CT is often regarded as a superior tool for
the detection of intra-tumoral calcifications within the eye cavity, however, it induces ionizing
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radiation, which has a more negative effect on children than adults. Furthermore, ionizing
radiation has been shown to modify the patient´s radio-susceptibility (RS), thus affecting
the carriers of the RB1 germline mutation that are responsible for retinoblastoma. Moreover,
there is very little evidence regarding the diagnostic accuracy of CT in the context of advanced
retinoblastoma [55], and thus, it is less recommended for imaging the disease [33].
Over the last decade, the ophthalmic community has become increasingly interested in Mag-
netic Resonance Imaging MRI [96], mainly due to the favorable tissue contrast and improved
image resolution [97]. MRI sequences provide a remarkable soft tissue information source,
with the resolution comparable to the information extracted from ]CT [98]. Additionally,
recent studies [14, 37] have provided direct evidence for the usefulness of MRI in both diag-
nosis and the treatment follow-up of retinoblastoma, and that the combination of both MRI
and US would be sufficient to account for all calcifications found using CT. Consequently,
quantitative analysis of the eye Magnetic Resonance (MR) images is needed to support the
diagnosis and therapy planning with a better and faster eye anatomy delineation. In this
context, the existence of a robust and accurate segmentation tool for eye MR images would
offer an unprecedented opportunity for multimodal patient specific eye modeling. That is,
combining modalities such as Fundus imaging, US with MRI for treatment planning of the
eye[14, 98–100].
Until now, the task of segmenting the eye in medical images has been completed predom-
inantly by using a pre-established set of parameters. EYEPLAN [101], a framework that es-
timated the shape of the lens, the cornea and the sclera, does so by combining parametric
spheres. In comparison, OCTOPUS [49], currently widely used in modeling the eye inside
CT, employs the same concept but models the eye as combinations of ellipsoids. Both these
methods require an expert to pre-select visual landmarks. In addition, they have constrained
modeling capabilities, as they limit the eye-growing pattern as a linear function dependent
on the age of the patients. As such, they do not accommodate for a free growing pattern
that is representative of a real eye population. The recent image processing techniques have
opened the door to designing more complex models, which enable the segmentation of more
regions of interest (ROI) within the eye. In 2006, Singh et al. [102] proposed a segmentation
method for MRI based on spherical meshes that leveraged the posterior corneal pole and a
sphericity modifying parameter. More recently, Bach Cuadra et al. [98] designed an algorithm
combining parametric active contours with an ellipsoid model, which offered more accurate
segmentations of the sclera and the lens on the CT and US images. Despite these advances,
the eye treatment planning is far from being optimal.
One key element lacking in the above-mentioned parametric models is the statistical infor-
mation that can be extracted from the variability of a population. This type of information is
offered by Statistical Shape Model (SSM). These models use a previously trained, constrained
model-based algorithm that can account for the deformation of the shape of a structure.
Among the SSM, the ASM, proposed by Cootes et al. [67], are among the most successful.
They have been applied to numerous medical imaging applications [68], mainly to construct
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automatic segmentation frameworks by using both intensity and shape variation informa-
tion [77, 103, 104]. Here, Ruegsegger et al. [99] proposed a semi-automated method, requiring
minimal user interaction to segment the sclera, the cornea and the lens on CT images of adult
patients [99].
With the aim of providing an accurate method for eye segmentations in MR images, we present
an eye model that can capture both the shape variation and the intensity information from
a set of gadolinium enhanced T1w GE VIBE MR sequences used for retinoblastoma imaging.
The proposed 3D MRI ASM is, to the best of our knowledge, the first statistical model of the eye
based on MRI data. Importantly, it also involves a fully automatic segmentation of the sclera,
the cornea, the lens and the VH. We evaluated our model on a sample of 24 images of healthy
children´s eyes and validated it quantitatively using a leave-one-out cross validation test.
Our experiments show an average DSC of 91.6±2.20% for the ROIs. In addition, we applied
our method on two pathological patient eyes with retinoblastoma and have quantitatively
highlighted the benefits of our approach with an average DSC of 93.45±0.93%.
2.2 Materials and Methods
Our segmentation procedure can be summarized as follows. We start by constructing an
atlas of the eye regions [105]. We then extract an eye PBSVM and couple it with the intensity
information to build an ASM. Then, to segment a new subject, we follow a two step process.
First, we automatically find a number of landmarks within the eye to initialize the alignment
of the model, and second, we fit the ASM to the volume. A visual depiction of our framework
can be seen in Fig. 2.1.
Figure 2.1 – Framework automatic segmentation of the eye : Block diagram representing
the fully automatic segmentation framework. We create a model with N-1 Patients and test
the performance on the remaining subject.
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2.2.1 Training data set and manual segmentation:
The dataset used to develop our statistical model is composed of 24 healthy eyes gathered
from children aged 3.29± 2.15 years (see Fig. 2.2, from 4m to 8y8m). All patient informa-
tion in our study was anonymized and de-identified by physicians prior to our analysis and
the corresponding institution approved the study. MR imaging was performed using a 3T
Siemens Verio (Siemens, Erlangen, Germany), with a 32-channel surface head coil attached.
The images are gadolinium enhanced T1w GE VIBE (TR/TE, 20/3.91ms, flip angle, 12 deg)
[52], and were acquired with two differing spatial resolutions: 0.416x0.416x0.399mm and
0.480x0.480x0.499mm. The images include the head of the patient, both eyes and the optic
nerves. Images are resampled to a common voxel spacing of 0.416x0.416x0.399mm. During
imaging, the patients were under general anesthesia [37].
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Figure 2.2 – Patient dataset Information : a) Dataset information distribution. b) Age vs.
Axial length. c) Age vs. Lens size. d) Age vs. Lens width. Highlighted values in red are Sub03,
Sub07, Sub14 and Sub15.
In order to validate our method, an expert radiologist manually segmented all volumes by
labeling the following anatomical structures: sclera, cornea, lens, VH and OD. As described
below, an atlas is then created based on the segmented volumes of every patient. Furthermore,
axial length, lens size and width statistics were extracted and compared with the age of
the patients. We observed a strong correlation between age and axial length (Fig. 2.2b), as
described by Fledelius and Christensen [106], but a weak correlation between age and lens
size and between age and width (Fig. 2.2c-d).
For initialization and detection of the eyes, we apply the method proposed by De Zanet et
al. [94], based on the Fast Radial Symmetry Transform (FRST) algorithm. We automatically
detect the center of both eyes in all patients (Fig. 2.3), even in the case of enucleation or
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pathology. From the dicom file orientation information, we define whether it is the left or right
eye. This information enables us to flip the volume over the transversal plane and mirror it for
both eyes when required. We then crop the MRI head volume into two smaller Volumes of
Interest Volume of Interests (VOIs) of size 40x40x40mm for both eyes. Next, we retrieve the
location of the center of the lens, the optic disc, and the VH (Fig. 2.3b) [94]. These 3 points
provide the initial alignment for building the atlas and for the fitting of a new patient.
Figure 2.3 – Detail of 3D MRI : a) MRI volume, highlighting automatic cropping region and
landmark initialization. b) Pre-processed MRI region of the eye including landmarks. c)
Segmentation results for the lens and the VH.
2.2.2 Atlas construction :
We apply a rigid (i.e. translation and rotation) pre-registration step to the whole patient
dataset. Both the center of the VH and the lens were used for the translation, and the optic
disc position was used for the rotation. We then compute the distance map of the manually
segmented regions, fuse them, and create a baseline atlas. Afterwards, we obtain, for each
patient, the deformation field (non-rigid free diffeomorphic demons) against the baseline
atlas [107]. Finally, we apply the mean deformation field to the baseline atlas to obtain the
atlas in natural coordinate system NCS [105].
2.2.3 Point-Based shape variation model (PBSVM):
We represent the surface of the atlas in NCS as a point cloud by using a mesh extraction
algorithm [108]. This is followed by a Gaussian smoothing and a decimation to the regions of
the sclera, the cornea and the VH by 85% and by 10% for the lens. The information lost during
the decimation step never induced an error over 0.01mm in average for all ROIs.
Once the surface is extracted, we warp the atlas back to the patient using non-rigid diffeomor-
phic registration [107]. The new atlas landmark positions for each subject are then transformed
to a tangent space (Eq. 2.1) to preserve the linearity of the PBSVM, as expressed by Cootes et
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al. [67] in
xt = |x¯|
2
x ∗ x¯ · x, (2.1)
where x are the original surface points vector, x¯ is the mean overall surface shape and xt is the
new projection of the surface points in the tangent space. The PCA [109] on the projection
is done to extract the principal components of the point cloud distribution in space. The
combined information is known as the shape variation model, and is stored in the form of
x ≈ x¯+Φb (2.2)
where x¯ is the mean shape, represented as a vector of t points, Φ= (ϕ1|ϕ2|...|ϕt ) is a matrix
which contains the eigenvectors corresponding to the variation of the model at each point,
b is a t-dimensional vector representing the modes of variation. By modifying the bi value
under the constraints ±
√
λi , i = 1..t , we constrain the model to be within the range of similar
shapes to the training set. For every position in b, λ is the eigenvalue corresponding to the
Φ matrix. We assume the shape to be represented as a normal distribution of points along
shapes ±3σi [67, 99, 105].
2.2.4 Active Shape Model (ASM) :
We connect the PBSVM described in the previous section with the MRI intensity information
and create an ASM. In contrast to CT, MRI does not provide fix intensity values across pa-
tients. Therefore, we use the standardization equalization algorithm proposed by Nyul and
Udupa [110] to standardize the dataset.
Once the dataset has been equalized, we pre-process the MRI volumes with an anisotropic
diffusion gradient filter, and window the image intensity to highlight the region of the eyeball
and lens. We fix an arbitrary common upper and lower threshold for the windowing and
extract the intensity information at each landmark position. Then, we compute the gradient
and the Sobel operators along the intensity profiles normal to the surface. Subsequently, we
compute the gradient for the sclera/VH and the Sobel for the lens.
We then select an even distribution of points [111] over the surface of the different regions from
the landmark point cloud list (350 points from the sclera-cornea and the VH, and 300 points
for the lens). We extracted the surface normal at these given points and compute the mean
gradient intensities or the mean Sobel profiles, as well as the covariance matrices. The length
of the extracted profiles depends on the region. We extract a normalized profile gradient along
11 pixels for the sclera, the cornea and for the VH, and 9 pixels length Sobel profile for the lens.
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2.2.5 Automated segmentation :
The segmentation of a new patient is as follows. First, the VOI is pre-processed in the same
way as the images were processed during the ASM construction; the VOI is not resampled and
maintains its original image resolution. We then scan the profiles normal to the surface of the
model. These profiles are compared to the intensity profiles provided by the ASM, and a new
matched point is set for each profile along the sampled voxels. The fitting is then reduced to an
optimization problem where the Mahalanobis distance to the model shape is minimized [67]
by reducing the overall distance between the current shape point and the matched point,
while constraining the model to be within the deformation range of the PBSVM. In contrast to
other work [99], the segmentation scheme that we apply here is twofold: we first fit the sclera
and the VH and then once the optimum is found, we fit the lens independently (Fig. 2.3c).
2.3 Results
We assessed our segmentation method using a leave-one-out cross-validation test of the
ASM. That is, we iterated over each patient, excluding it from the ASM construction and
automatically fit the generated model to the excluded patient. The quality of the segmentations
were evaluated by computing the DSC, where we considered the manual segmentation as the
ground truth DSC = 2 · |A∩B ||A|+|B | .
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Figure 2.4 – Leave-one-out cross validation : a) Mean and standard deviation of DSC for
independent and combined shapes. b) Mean distance error for every eye region and combined
mean error.
Furthermore, for each patient and eye region, we computed the mean distance error between
the patient ground truth surface and the automatic segmentation result (Fig. 2.4b). We report
the distribution of mean distance error per point across all patients and regions in Fig. 2.5.
The average DSC over all subjects was 94.90±2.12% for the sclera and the cornea, 94.72±1.89%
for the VH and 85.16±4.91% for the lens. Fig. 2.4a) summarizes the mean DSC. The mean
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distance error is 0.33± 0.17mm for the sclera and cornea, 0.30± 0.15 mm for the VH and
0.17±0.07mm for the lens (Fig. 2.4b), with a mean global distribution error of 0.27±0.09mm
per patient. The entire segmentation process takes 14s. per eye on average using a Pentium i7
3,4 GHz QuadCore 8GB RAM.
Finally, we applied our segmentation on two patients with retinoblastoma. In these cases, the
model was robust in detecting the presence of tumors, even when these were large (Fig. 2.6).
We obtained a DSC overlap of 94%, 93.98%, and 92.37% on average for sclera+cornea, VH and
lens, respectively.
2.4 Discussion
The present work describes a method for automatic segmentation of MRI of the eyes based on
a 3D ASM. Our approach is, to the best of our knowledge, the first framework for automatic
extraction of the eye shape with dedicated regions of the sclera, the cornea, the VH and the
lens in the MRI.
We have demonstrated that our model enables to accurately segment the eye, with an average
error for all ROIs always under the minimum resolution threshold (0.399mm) and never
reaching more than 1.2mm (Table 2.1). The results highlight an accurate fit for the posterior
part of the VH, where the macula and the optic disc are located (Fig. 2.5a). Furthermore, we
noticed a bias towards having over segmentation errors in the frontal part of the eye (Fig. 2.5b-
c). This situation caused the lens to yield a lower average DSC (85.16%) than for other regions.
The results can be explained due to the small size of the lens in contrast to the sclera and the
VH. This limitation of the DSC index for small regions was already reported by several authors
in the field [112, 113].
Within the dataset, we identified an outlier ((Table 2.1, Sub07) that presented the lowest
accuracy during segmentation across all ROIs. This is due to the small size of the eye (youngest
patient with 4 months) that made him not well represented by our model. In the future, a
larger dataset with greater number of younger patients (< 6 months) would address this issue.
Furthermore, we also observed that Sub03, Sub14 and Sub15 perform below average during
the lens fitting. Nevertheless, there is a general trend towards robust segmentation of the
sclera, cornea and vitreous humor, even in cases with a strong variation in eye axial length
size. The final outcome is that lenses in eyes whose size are closer to the mean shape size are
better segmented than extreme-size eyes (Table 2.2).
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Figure 2.5 – Mean distance error distribution : Mean distance error distribution with respect
to the manual segmentation. a) unsigned and b-c) signed distance error to display bias towards
over-segmentation or under-segmentation.
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Our work demonstrates a novel application of statistical modeling techniques to treatment
planning and diagnosis confirmation of intraocular tumors, such as retinoblastoma. The
speed, robustness and reliability of the present method are evidence that it can accommodate
the variability existing in the size of eyes, as well as solving minor eye orientation issues during
the fitting process. Similarly to the presented children eye model and pathological eyes, our
framework can be directly applied to create a model for adults, for instance, for delineation
of the uveal melanoma prior to therapy planning. Uveal melanoma presents a very similar
MRI imaging conditions to retinoblastoma, therefore, leveraging the current framework to
pathological adult eyes could be the next step.
2.5 Conclusions
Although previous works attempted to delineate or characterize the MRI imaged eyes using a
manual qualitative evaluation, we are first to report quantitative results on the segmentation
accuracy on MRI. The procedures that we used can provide the basis for objective assessment
of the quality of the model fitting in the eye MRI, as it did in other image modalities such as
CT. Furthermore, the robustness of the model during the segmentation of pathological MRI
volumes indicates an important and promising step towards facilitated treatment planning
and tumor extent follow-up. A higher MRI diagnostic accuracy for retinoblastoma, in particular
for the detection of prelaminar optic nerve and choroidal invasion, is crucial for designing
effective treatment strategies. Thus our future work will focus on quantitative evaluation in
larger datasets.
Figure 2.6 – Pathological eye segmentation : Patients with retinoblastoma in a) and e).
Automatic eye segmentation for a small tumor present in the retina b), c), d). Robust fit of the
VH and the Lens for large tumor in f), g), h).
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To our knowledge, this framework is the most accurate and robust tool yet to fully and auto-
matically segment the lens, sclera, cornea and VH regions in MRI. The presented approach
provides a solution for reducing the time spent in delineating the eye shape and is likely to
advance current ocular tumor treatment planning and diagnosis techniques.
Table 2.1 – Dice Similarity Coefficient (DSC) for Active Shape Model during leave-one-out
cross-validation test. Mean overall error in (mm)/
Sclera VH Lens Mean Sclera Sclera Max. VH VH Max Lens Lens Max
DSC Dev. Scl. Dev. VH Dev. Lens
Sub01 96.23 95.6 86.75 92.93 0.36 0.07 1.19 0.39 0.08 1.19 0.1 0.03 0.57
Sub02 92.01 94.51 84.15 90.16 0.33 0.1 0.79 0.25 0.06 1.15 0.14 0.04 0.59
Sub03 94.89 94.8 79.85 89.34 0.28 0.09 1.59 0.23 0.06 0.99 0.16 0.04 0.57
Sub04 95.94 95.39 86.7 92.73 0.39 0.11 1.59 0.19 0.06 1.15 0.15 0.04 0.57
Sub05 96.51 95.94 81.79 91.57 0.29 0.06 0.93 0.34 0.08 1.24 0.08 0.03 0.57
Sub06 93.62 95.49 92.14 93.35 0.19 0.06 0.57 0.14 0.04 0.83 0.19 0.04 0.58
Sub07 87.46 87.94 76.39 84.2 1 0.22 2.38 0.87 0.19 2.46 0.38 0.1 1.25
Sub08 94.36 95.22 87.09 92.14 0.21 0.05 0.83 0.17 0.04 0.83 0.27 0.06 0.83
Sub09 97.27 96.69 87.46 93.37 0.25 0.05 0.9 0.3 0.06 1.19 0.07 0.02 0.41
Sub10 95.03 94.05 89.21 92.8 0.35 0.12 1.52 0.43 0.13 1.51 0.12 0.04 0.59
Sub11 96.45 97.24 90.07 94.4 0.45 0.07 1.27 0.22 0.06 0.9 0.11 0.03 0.57
Sub12 95.27 95.32 90.07 93.76 0.25 0.07 0.9 0.28 0.08 1.25 0.17 0.04 0.59
Sub13 94.66 93.67 85.6 91.35 0.38 0.16 2.03 0.43 0.17 2.04 0.17 0.04 0.83
Sub14 96.29 95.95 78.43 90.5 0.18 0.06 1.15 0.25 0.09 1.46 0.21 0.05 0.57
Sub15 96.17 95.01 71.36 87.69 0.19 0.05 0.79 0.26 0.08 1.71 0.25 0.07 0.93
Sub16 91.47 93.67 86.25 90.78 0.34 0.1 0.58 0.23 0.06 0.9 0.17 0.04 0.71
Sub17 96.54 95.13 83.6 91.7 0.19 0.05 0.92 0.15 0.04 0.83 0.23 0.07 0.93
Sub18 95.46 94.32 87.11 92.41 0.23 0.05 0.93 0.2 0.05 0.83 0.14 0.04 0.57
Sub19 93.8 91.51 91.52 92.34 0.23 0.06 0.83 0.26 0.06 0.58 0.17 0.04 0.59
Sub20 96.8 95.79 89.63 94.15 0.34 0.08 1.25 0.3 0.06 0.93 0.17 0.04 0.59
Sub21 95.71 95.77 83.58 91.6 0.2 0.06 1.19 0.22 0.08 1.27 0.08 0.03 0.42
Sub22 95.3 92.96 85.4 91.14 0.27 0.07 1.15 0.25 0.08 0.79 0.16 0.04 0.83
Sub23 94.82 95.89 85.99 92.44 0.5 0.09 1.31 0.35 0.07 1.24 0.12 0.04 0.58
Sub24 95.5 95.43 83.72 91.66 0.51 0.04 0.99 0.47 0.04 0.93 0.21 0.07 0.93
Mean 94.9 94.72 85.16 91.6 0.33 0.08 1.15 0.3 0.08 1.18 0.17 0.04 0.67
SD 2.12 1.89 4.91 2.2 0.17 0.04 0.43 0.15 0.04 0.43 0.07 0.17 0.19
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Table 2.2 – Patient Dataset Information : Age, lens size, lens width and axial length
Age (y.) Lens Size (mm) Lens Width (mm) Axial Length (mm)
Sub01 3.51 7.48 3.94 21.44
Sub02 3.877 7.79 3.85 21.41
Sub03 6.488 7.57 3.46 22.32
Sub04 3.838 8.44 3.89 22
Sub05 0.696 7.7 3.68 20.2
Sub06 4.926 8.09 4.07 21.65
Sub07 0.356 6.95 3.53 18.87
Sub08 4.033 8.44 3.97 22.51
Sub09 5.373 8.12 3.91 20.76
Sub10 1.036 7.85 3.6 20.53
Sub11 2.071 8.17 3.6 20.55
Sub12 2.756 8.01 4.24 20.91
Sub13 2.649 7.93 4.16 20.13
Sub14 7.197 7.97 3.91 22.31
Sub15 4.49 8.42 4.56 23.1
Sub16 8.762 8.17 3.76 22.85
Sub17 3.236 7.52 4.11 21.25
Sub18 2.553 8 4.27 22.45
Sub19 3.274 8.25 4.23 21.57
Sub20 1.044 8.22 3.91 20.56
Sub21 1.841 7.65 4.04 21.03
Sub22 3.047 8.68 4.25 21.14
Sub23 1.121 8.04 4.25 20.71
Sub24 0.723 7.24 3.78 20.37
Mean 3.29 7.94 3.97 21.27
SD 2.15 0.4 0.27 1
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Multi-channel MRI segmentation of
eye structures and tumors using
patient-specific features
This chapter continues with the work introduced in Chapter 2 and presents the first attempt
to perform automatic multi-channel MRI segmentation of ocular tumors for T1w VIBE and
T2w. A 10-page journal paper was submited to the Plos One Journal at the time of this thesis:
C. Ciller, S.I. De Zanet, K. Kamnitsas, P. Maeder, B. Glocker, F.L. Munier, D. Rueckert, J-P.
Thiran, M.B. Cuadra and R. Sznitman, “Multi-channel MRI segmentation of eye structures
and tumors using patient-specific features”. A preliminary version of this work was originally
submitted in the form of an 8-page conference paper to the Medical Image Computing and
Computer Assisted Intervention conference in March 2016.
3.1 Introduction
Common forms of ocular cancer are related to high morbidity and mortality rates [33]. Imaging
of these tumors has generally been performed using 2D Fundus imaging, 2D US or 3D CT.
Recently, however, Magnetic Resonance Imaging (MRI) has gained increased interest within
the ophthalmic community, mainly due to its remarkable soft tissue intensity contrast, com-
parable spatial resolution capabilities to 3D CT and non-ionizing properties [37]. Concretely,
MRI is becoming a key modality for pre-treatment diagnostics of tumor extent, especially for
retinoblastoma in children, and is gaining a great interest for treatment planning with external
beam radiotherapy of uveal melanomas in adults.
For the case of retinoblastoma, a tumor that most often takes root and develops from the retina
into the vitreous humor of children eyes [37] (Fig. 4.1), MRI is required to observe possible
tumor invasion within the optic nerve, or to evaluate the appearance of recurrent tumors
after treatment. Occasionally, treated tumors present second recurrent malignancies under
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the calcified area, a pathology that can more easily be observed via MRI [33]. In this context,
having accurate 3D segmentations of eyes with pathology would help better characterize and
quantify intraocular tumors more effectively. This would not only allow for reliable large-scale
longitudinal treatment-response studies but would also allow for direct imaging and targeting
of tumors during treatment procedures, such as the applied in brachytherapy/cryotherapy to
children with retinoblastoma [31].
T1w	-	VIBE
T2w
T1w	-	VIBE
T2w
a) b) Segmenta�on	T1w
Segmenta�on	T2w
Segmenta�on	T1w
Segmenta�on	T2w Endophytic
Tumor
Sclera
Cornea
Lens
Vitreous Humor
c)
Figure 3.1 – Patients with retinoblastoma (a)-(b) Two example patients imaged with 3D T1w
VIBE & T2w MRI (c) The eye lens (dark blue), vitreous humor (red) and sclera / cornea (light
blue) are highlighted. Endophytic tumors delineated in yellow.
Unfortunately, and in contrast to neuro(-brain)imaging [114–119], the use of computer-aided
techniques for 3D segmentation of the eye remains limited in ocular MRI and, to the best
of our knowledge, none address the eye tumor segmentation problem. The accuracy of the
existing brain tumor techniques strongly relies on many imaging sequences and on the tumor
type they are tailored to (e.g. glioma or meningioma,). Thus, their direct application to ocular
tumors is not straightforward, considering that only a few contrast images are usually available
and, most importantly, they appear as extremely small structures as compared to brain tumors
(Fig. 3.1-a)).
Today, existing methods for ocular segmentation of healthy structures in MR (and CT) rely
on semi-automatic techniques based on parametrical models dedicated to segment the eye
regions [49], thus only allowing for a coarse segmentation of different eye parts (e.g. eye lens
or VH). Along this line, Active Shape Models (ASMs), originally introduced by Cootes et al.
[67] have recently been proposed by our group to more precisely delineate eye anatomy using
T1w VIBE MR and CT images [2, 99]. In that work, the main goal was to delineate healthy eye
structures, but the challenge of eye tumor delineation has yet to be addressed.
In this chapter we introduce a novel segmentation framework dedicated to the ocular anatomy.
We present a set of eye delineation techniques in 3D MRI, both for healthy structures and for
pathological tissue. Our contributions can be summarized as follows:
• We present a new Pathological Eye Model (PM) of the eye, built out of pathological
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patient eyes and compare the results with the HM presented in [2], achieving better
healthy tissue segmentation performance.
• We introduce novel EPSF, derived from our pathological ASM, which help characterize
pathological tissue, even when only small amounts of training data is available.
• We introduce a novel automatic segmentation framework tailored to ocular tumors.
Similar to top ranking algorithms for brain tumor segmentation [120], our method
makes use of a Markov Random Field (MRF) to represent the presence of healthy and
pathological tissue, allowing for both local and neighborhood information to be utilized
in a joint manner. Unlike existing brain tumor techniques, however, we encode prior
information of the tumors by means of an active shape pathological model, contrasting
the use of typical brain atlas priors or existing ASMs of healthy eyes.
• Furthermore, we validate our framework on a clinical dataset of T1w VIBE and T2w
MRI from retinoblastoma patients and show that when EPSF are used, performance
differences between state-of-the-art deep networks and other simpler classifiers such as
RF are minor and improvements are visible across all cases.
We divide the following sections. First, the materials and methods section presents the clinical
dataset, the segmentation of the healthy structures, the eye feature extraction process and
our mathematical framework. Second, results comparing the classification performance
between different experiments for both healthy tissue segmentation and pathological eye
tissue delineation are presented. Third, we discuss about current eye treatment strategies and
show the contributions of the presented approach for the future of ocular tumors in the MRI.
3.2 Materials and Methods
Our framework first makes use of an ASM [67] trained on patient data that contains tumors
and which we refer to from now on as Pathological Model (PM). Note that this model is trained
exclusively on pathological eye MRI data, in contrast to our previous work [2, 99]. This model
aims at delineating the regions of the sclera, the cornea, the lens and the vitreous humor in
an automatic fashion. From this pathologically-based ASM, we propose the use of EPSF to
characterize pathological tissue within healthy anatomy. We then leverage these features in
a classical Markov Random Field (MRF) model to accurately segment eye tumors. Fig. 3.2
illustrates the complete framework which we now describe in detail.
3.2.1 Dataset
Our dataset is composed of 16 children eyes with endophytic retinoblastoma. The volumes
represent a section of the head of the patient, both eyes and the optic nerve. MRI was per-
formed in a 3T Siemens Verio (Siemens, Erlangen, Germany), with a surface head coil of
32 channels. Acquisition was done under general anesthesia. The images are gadolinium
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T1w VIBE
T2w
Classification 
(RF / CNN)
Graph-Cut
Vitreous Humor DMLens Humor DM Tumor Probabilistic Prior
Automatic Eye 
Segmentation (ASM)
Eye Patient Specific Features (EPSF)
Input Volumes
Registration
1ring - T1w 1ring - T2w 1ring Anis. - T1w
Fully Automatic Eye Segmentation 
Standard Features (STD)
Superpixel - T1w
Superpixel - T2w
Pre-processing and Segmentation of Eye Anatomy Feature Extraction
Eye Masking
--
Eye Tumor 
Segmentation
Figure 3.2 – Proposed framework for automatic whole eye segmentation. T1w and T2w 3D
volumes are combined with EPSF features. These features are used to train a RF / CNN
classifier, serving as the data term in Graph-Cut optimization.
enhanced T1w VIBE (repetition time/echo time, 20/3.91 ms; flip angle, 12°) acquired at two
different spatial resolutions (0.416×0.416×0.399 mm3 and 0.480×0.480×0.499 mm3, respec-
tively) and T2w (repetition time/echo time, 1000/131 ms; flip angle, 120°) with a resolution
of 0.453×0.453×0.459 mm3. All patient information in our study was anonymized and de-
identified by physicians prior to our analysis, and the study was approved by the Cantonal
Research Ethics Committee of Vaud. For each eye, the sclera, the cornea, the vitreous humor,
the lens and the tumor were manually segmented by an expert radiologist (see Fig. 3.1 and
3.2). We use these manual segmentations as ground truth for quantitative comparisons.
3.2.2 Pre-processing and segmentation of eye anatomy
Starting from the patient head-section MRIs containing ocular tumors, we begin by automati-
cally locating the ROI around each eye. Following the landmark-based registration described
in [2, 94], we detect the center of the VH, the center of the lens and the optic disc and use this
information to align the eyes to a common coordinate system. This pre-processing allows
us to form a coherent dataset representing the same anatomical regions across subjects. In
particular, we let our image data X for a patient n consist of both T1w VIBE and T2w volumes
which have been co-registered using a rigid registration scheme, rescaled to a common image
resolution, intensity-normalized for all eye volumes [110] and cropped to the ROI.
Using manual delineations of the sclera and the cornea, the eye lens and the VH we learn
an ASM [67] for these structures jointly. Note that we do not include the delineations of
tumors inside the model, but implicitly encode this information from the profile intensity
information for the sclera and the VH, as can be seen in Fig. 3.3. With this, we can segment
such healthy structures in any subsequent eye MRI. As we will show in Sec. Results, learning
an ASM on pathological patient data provides improved segmentation accuracy as compared
to healthy-patient ASM models eye models [2].
Furthermore, in order to ease the process of learning the tumor classifier, we will only consider
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PRE-PROCESSINGPre-Processing Pathological Model
ASM Profile Intensity Information
a) b) c)
Figure 3.3 – Learning a Pathological Eye Model (PM). We follow the steps in [2] to (a) auto-
matically detect the eye in the 3D MRI, followed by a set of b) image pre-processing techniques
to learn information of pathological and healthy structures jointly using c) intensity profiles
containing pathological information.
voxels at a Euclidean distance of θ = (0,2) mm from the VH delineation result. That is, we
only evaluate voxels that are close and within the VH, upper bounded by the maximum
segmentation error of the ASM (see Fig. 3.2, brown-colored box). The main purpose at this
stage is to focus exclusively on the tumor segmentation, reducing the observable region to the
VH plus an additional confidence at a distance θ from the boundary.
3.2.3 Feature extraction
We let fST Di at voxel location i denote STD defined as the concatenation of T1w and T2w
voxel intensities, the anisotropic T1-weighted (A-T1w), and the average 6-voxel von-Neumann
neighbors (6 nearest neigbors) of the T1w, T2w and A-T1w. On their own such features provide
standard intensity information to the appearance of both healthy and pathological tissue (see
Fig. 3.2, brown-colored box).
Given a segmentation of healthy eye structures, we are interested in establishing image features
that provide appearance and contextual information regarding pathological tissue as well. To
achieve this goal, we begin by applying the learned ASM (see Sec. Pre-processing) to the eye
MRI, thus providing a delineation boundary for the lens and VH. Then, we assign to each
voxel i in the volume a rank relative to the Euclidean distance to the surface border of both
the lens and the VH. More specifically, the rank at each voxel is defined as,
fli =minb∈Bl |i −b|
2
2, and f
vh
i = minb∈Bvh |i −b|
2
2, (3.1)
where Bl and Bvh are the boundary voxels of the eye lens and VH, respectively. These features
can be interpreted as distance maps resulting from the pathological ASM segmentation.
In addition, in order to leverage prior information on the tumor locations, we also use the
ground truth tumor locations within our training set, to construct a tumor location likelihood
feature, fti = 1N
∑N
n1 Yi , where Yi = 1 if the voxel at location i is part of the tumor and where N is
the total number of volumes in the training set. Smoothing ft is then performed by using a 3D
Gaussian kernel (σ= 3 mm) to regularize the tumor prior. This value was arbitrarily chosen as
to create a smooth yet precise representation of the tumor distribution inside the eye. In Fig.
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3.2 you can find an example of these feature maps.
Our EPSF for each voxel is then constructed by concatenating the following rank-values:
fEPSFi = [fli , fvhi , fti ]. As illustrated in Fig. 3.2, this effectively characterizes patient-specific
anatomy (via fli , f
vh
i ) and a location specific tumor likelihood (via f
t
i ), allowing both local and
global information to be encoded in a compact feature at voxel level.
3.2.4 Eye Tumor Segmentation
General mathematical framework
Now, to segment the eye tumor tissue, we make use of a MRF to model the joint distribution
of all the voxels P (Y , X |M ), where Y = ∪i Yi , Yi ∈ {0,1} represents the presence of a tumor
at location i , X is the MR volume andM =M1, . . . ,MS , represents the different healthy eye
structures,
P (Y , X |M )= 1
Z
∏
i
P (Xi |Yi ,M )
∏
j∈Ni
P (Yi ,Y j |M ), (3.2)
with normalization factor Z , likelihood model P (Xi |Yi ,M ) and smoothness prior P (Yi ,Y j |M ).
From this, we can simplify this expression to,
P (Y , X |M )= 1
Z
∏
i
P (fi |Yi )
∏
j∈Ni
P (Yi ,Y j ), (3.3)
by assuming that (1) the prior is independent of the underlying eye structure and that a single
model accurately describes the neighborhood interactions and (2) instead of modeling the
likelihoods as a function of a given structure, we approximate it by leveraging our patient-
specific features that are implicitly indexed on M . Using this model, we can then use a
standard Graph-cut optimization [121, 122] to infer the tumor segmentation. The presented
approach is particularly powerful because the topology of our segmentation is not restricted
to a single structure and allows refining segmentation on multiple isolated parts.
Likelihood prior
The likelihood prior, defined as P (fi |Yi ), provides the probability for every voxel i within the
3D volume to represent either tumor or healthy tissue Yi = {0,1} . In this work we conduct a
set of experiments with two scenarios, a) a rather simplistic voxel-based RF classifier and b)
a state-of-the-art CNN [119], which leverages the power of 3D convolutions to perform the
same classification task.
RF classification: We train a RF classifier [123] with 200 trees, using all positive voxels (Yi = 1)
in the training set and 20% of the negative voxels (Yi = 0) to balance the number of samples.
As in [124], SLIC superpixels [125] are computed on each 2D-MR slice (i.e. region size of 10
voxels and a regularization factor r = 0.1), from which mean superpixel intensity at position i
was aggregated for both T1w and T2w. SLIC features support the voxel-wise classification by
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providing intensity context based on the surrounding area.
The number of trees was selected by reaching convergence with Out-of-Bag estimation, testing
RF performance with a varying number of trees from 50 to 1000 and choosing the minimum
number of trees to reach convergence.
CNN classification: We train a modified version of the 3D CNN presented in [119], known as
DeepMedic. The model we employ consists of 8 convolutional layers followed by a classification
layer. All hidden layers use 33-sized kernels, which leads to a model with a 173-sized receptive
field. In this task, where the ROI is smaller than for brain cases ( 80x80x83 voxels), processing
around each voxel is deemed enough for its classification and thus, the multi-resolution
approach of the original work is not used. We reduced the number of Feature Maps (FM) in
comparison to the original model {15,15,20,20,25,25,30,30} at each hidden layer respectively,
not only to mitigate the risk of overfitting given the small dataset, but also to the reduce the
computation burden.
To enhance the generalization of the CNN, we augment the training data with reflections
over the x, y and z axis. We use dropout [126] with 50% rate at the final layer, which counters
overfitting by disallowing feature co-adaption. Finally, we utilize Batch normalization [127],
which accelerates training’s convergence and also relates the activation of neurons across a
whole batch, regularizing the model’s learnt representation. The rest of DeepMedic parameters
were kept similar to the original configuration [119], as preliminary experimentation showed
satisfactory behavior of the system.
Smoothness prior and refinement
Following the mathematical model in Eq. 3.3, we are interested in having a smoothness prior
that favors pairs of labels that are deemed similar to one another. In our case, we estimate the
similarity intensity values from both T1w and T2w with a parametric model of the form
P (Yi ,Y j )=α ·e
− 1
2σ2T1
(T i1−T j1 )2 + (1−α) ·e
− 1
2σ2T2
(T i2−T j2 )2
, (3.4)
where T i1 is the intensity value at voxel i of the T1w VIBE volume (and similarly for T
i
2 ),α ∈ (0,1)
is a bias term between T1w and T2w importance and where (σ2T1 ,σ
2
T2
) are the voxel intensity
variances of tumor locations in T1 and T2.
3.3 Results
3.3.1 Contribution of Pathological Eye Model
We performed a leave-one-out cross validation experiment on the presented Pathological
Model (PM). We compare its accuracy with our previous work [2], a Healthy Model (HM)
constructed of 24 healthy eyes. We furthermore tested the performance of combining both
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the HM and the PM into a Combined Model (CM) built out of 40 patient eyes (24 healthy and
16 pathological). Table 3.1 reports the DSC accuracy, which measures the volume overlap
between our results and the GT, for the three different models (i.e. PM, HM and CM) when
segmenting healthy tissue on our pathological patient dataset. We observe that the PM
outperforms the existing HM on average by a ≈ 4.5% and the CM by a ≈ 3.5% (statistical
significance evaluated using a paired t-test showing a p < 0.05 for both cases).
Sclera Vitreous Humor Lens Average
PM (%) 94.62±1.9 94.52±2.36 85.67±4.68 91.51±1.49*
HM - [2] (%) 92.27±4.13 91.62±4.42 76.97±20.28 86.95±9.24
CM (%) 92.45±2.99 91.85±3.07 79.22±14.08 87.84±6.38
Table 3.1 – Eye Anatomy DSC : Our Pathological Model (PM) shows more accurate results
than the Healthy Model (HM) from [2] and the Combined Model (CM), especially for the
region of the lens. (∗) p < 0.05.
3.3.2 Contribution of EPSF for tumor segmentation
We evaluated the tumor segmentation performances of our strategy when using a RF and a
CNN for the MRF likelihood model. In both cases, we tested the performance of fSTD features
only and combined fSTD,EPSF features as well. For each scenario we optimized θ using cross
validation, giving values of θ = 0 mm for RF-STD and θ = 2 mm otherwise. Fig. 3.4-a) indicates
the relevant contribution of EPSF, even when trained on very small amounts of data for the
RF classifier. Here we see EPSF provides more robustness towards improving the classifier’s
ability to generalize when trained with limited amounts of data. Fig. 3.4-b) illustrates the ROC
performance of the likelihood models and the different feature combinations. In particular,
we see that regardless of the classifier used, EPSF provide added performance in the likelihood
model. Similarly, improved segmentation performances are attained with EPSF once inference
of the MRF is performed, as depicted in Fig. 3.4-c). Optimal parameters for the smoothness
term are α= 0.3, λ= 0.7 for RF and α= 0.4, λ= 0.5 for CNN. Table 3.2 illustrates this point
more precisely by showing the average DSC and Hausdorff Distance (HD) scores before and
after MRF inference is performed and with different combinations of classifiers and features.
RF+EPSF RF+STD CNN+EPSF CNN+STD
DSC [%] 36.16±27.85 24.49±22.25 56.87±29.38 53.67±24.29
DSC (GC) [%] 58.50±32.07 46.15±34.88 62.25±26.27 57.64±28.35
HD (GC) [mm] 0.641±0.884 3.414±3.874 0.175±0.062 0.266±0.172
Training time [min] 2.36 ¦ 2.21 ¦ 150 † 150 †
Table 3.2 – DSC performance : DSC for different scenarios before and after graph-cut (GC)
inference. Hausdorff Distance (HD) after GC inference. Experiments were computed on ¦:
Macbook Pro Intel-Core™ i7 16GB - 2,5 GHZ & †: Intel-Core™ i7 6700 32GB with Nvidia GTX
Titan X®.
48
3.4. Discussion
RF: 15/1 - 12/4 - 8/8
FPR
TP
R
0 0.1 0.2 0.3
0.5
0.55
0.6
0.65
0.7
0.75
0.8
0.85
0.9
0.95
1
RF - EPSF (15/1):0.96...
RF - STD (15/1):0.886...
RF - EPSF (12/4):0.951...
RF - STD (12/4):0.873...
RF - EPSF (8/8):0.937...
RF - STD (8/8):0.86...
RF // CNN ROC
FPR
TP
R
0 0.1 0.2 0.3
0.5
0.55
0.6
0.65
0.7
0.75
0.8
0.85
0.9
0.95
1
RF - EPSF:0.96...
RF - STD:0.886...
CNN - EPSF:0.992...
CNN - STD:0.967...
False Positive Rate False Positive Rate RF-STD RF-EPSF CNN-STD CNN-EPSF
Di
ce
 S
im
ila
rit
y C
oe
ffic
ien
t
Tr
ue
 P
os
itiv
e 
Ra
te
Tr
ue
 P
os
itiv
e 
Ra
te
1.0
0.8
0.6
0.4
0.2
0.0
DSC: RF vs. CNN + Graph-Cut (GC)RF vs. CNN: ROCRF-ROC: 15/1 - 12/4 - 8/8 (train/test)a) b) c)
Figure 3.4 – Classification performance. (a) ROC curve depicting the effect of varying
amounts of (training/test) data for RF classification with and without EPSF. (b) ROC curve for
both experiments (CNN / RF) with STD and with EPSF. (c) DSC tumor segmentation results
for STD vs. EPSF. The latter shows better results for both cases (∗∗= p < 0.01).
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Figure 3.5 – DSC vs. Tumor size. Average results for different combination of classifiers and
feature sets. EPSF improves overall classification results over STD features consistently.
In Fig. 3.5, we show the DSC performance of the different features and classifiers as a function
of tumor size for each patient in the dataset. Note that despite ocular tumors being smaller
than brain tumors, DSC values are in line with those obtained for brain tumor segmentation
tasks [120]. This illustrates the good performance of our strategy even though DSC is negatively
biased for small structures. Except for the two smallest tumors in our dataset (< 20 voxels),
DSC scores attained are good, with a HD under the MRI volume’s resolution threshold for
CNNs. Our quantitative assessment is supported by the visual inspection of the results (see
Fig 3.6).
3.4 Discussion
This work introduces a multi-sequence MRI-based eye and tumor segmentation framework.
To the best of our knowledge, this is the first attempt towards performing qualitative eye
tumor delineation in 3D MRI. We have presented a PM of the eye that encodes information
of tumor occurrence as part of the ASM for various eye regions. Introducing pathological
information results in a more robust model (with a significantly lower standard deviation),
able to improve segmentation for the regions of the sclera, the cornea, the vitreous humor
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Figure 3.6 – Example segmentation results. The tumor ground truth is delineated in red.
Probability Maps, P (fi |Yi ), for worst (RF-STD) and best (CNN-EPSF) scenarios. Final column
shows the pathological model (PM) eye segmentation results.
and the lens. The delineation is followed by a binary masking θ, where the complexity of
the tumor segmentation problem is reduced to the eyeball region, and is upper bounded by
the maximum euclidean distance error during segmentation. Despite the simplicity of the
masking, the gain in performance is significant for all the tested classifiers.
From a clinical perspective, we have presented a new tool for a) measuring the eye tumor
size, a task which is now only performed qualitatively in 3D MRI, b) ocular tumor follow-ups,
by providing a qualitative estimation of cancer volume variations to enable tracking of the
effectiveness of treatment (e.g tumor shrinking over time, ...) as well as c) a new approach
to study cancer recurrence. Note that recurrence appears often for calcified retinoblastoma
tumors [37], developing under the visible area a clinician would observe during Fundus and
US, thus making MRI the sole option to detect recurrent tumors under calcified tissue inside
the eye.
Moreover, when it comes to evaluating the quality of the segmentation, there is a remarkable
difference between the delineation of small (< 20 voxels) and big ( > 2k voxels) pathologies.
Compact retinoblastomas can be up to four orders of magnitude smaller than such cases.
This variation poses a challenge for the presented framework and highly influences the final
volume overlap, measured in the form of DSC. To provide a more reasonable measure of the
quality of the delineation, we opted for the Hausdorff Distance (HD), a widely spread method
in medical imaging to measure segmentation based on distance to the surface GT. Having a
look at both DSC and HD, we clearly notice that despite the DSC of the RF with EPSF being
larger than the CNN with STD features, the latter offers a more robust segmentation1. In the
future, the presented work should be evaluated with a larger dataset where more samples with
tumors from varying sizes are investigated. Also, tumors with similar imaging conditions, such
as uveal melanoma, would be good candidates for performing the evaluation. Furthermore,
and in order to potentiate the use of the presented tool, we will offer a functional copy of
1Supplementary material includes extended results for DSC.
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the pipeline alongside a minimal dataset for segmenting ocular tumors in the eye in 3D MRI
online2 .
One of the most important constraints of current eye MR imaging in ophthalmology are the
limitation in terms of resolution, the scanning time, and the difficulty to disentangle small
tumors from the choroid, towards both the inside (endophytic) and the outside of the eyes
(exopythic). To compensate for this, multiple image modalities (e.g. US, CT, Fundus) are
evaluated in order to decide about the best treatment strategy. Among the current challenges
to improve this decisive step, one of the most relevant is to find a way to connect multiple
image modalities in a robust manner. That is, connecting image modalities at different scales
(MRI, Fundus, OCT or US) and use common anatomical landmarks to validate the multi-
modal fusion. This contribution would not only imply refining the quality of the delineation
and treatment based on MRI (such as the framework presented in this manuscript) and
other medical image sequences, but it would also support clinicians during the process
of decision making, evaluation of tumor extent and patient follow-up, enabling co-working
clinical specialists from various backgrounds and modality preferences into the same common
perspective.
3.5 Conclusion
We introduced a framework for multi-sequence whole eye segmentation and tumor delin-
eation in MRI. We leveraged the use of pathological priors by means of an ASM and introduced
a new set of features (EPSF) that characterize shape, position and tumor likelihood. When
combined with traditional features, EPSF are robust and effective at segmenting pathological
tissue, particularly when tumors are small. Our approach shows comparable DSC and HD
performances to state-of-the-art brain tumor segmentation even when limited amounts of
data are available. Both RF and CNN show improved results with our features, while the former
performs almost as equally as the latter and is trained in a fraction of the time.
2Available at http://www.unil.ch/mial/home/menuguid/software.html
51

4
Improving multimodal eye tumor
analysis by fusion of MRI and Fundus
Image Photography
This chapter presents a novel registration method in order to tackle the fusion of pathological
MRI and Fundus Image Photography, towards providing clinicians with a simultaneous evalu-
ation tool for ocular tumors accross modalities. We first provide an overview of the related
work in the field [94], and continue with a deeper coverage of the techniques required to
achieve multi-modal fusion of MRI and Fundus [2, 22].
The work developed in this chapter is in preparation to be submitted as: C. Ciller, S. I. De
Zanet, P. Maeder, A. Pica, F. L. Munier, J-P. Thiran, R. Sznitman and M. B. Cuadra “Topographic
Fundus Mapping: Improving multimodal eye tumor analysis by fusion of MRI and Fundus
Image Photography”, to the journal IEEE Transactions on Medical Imaging.
4.1 Introduction
Retinoblastoma and uveal melanoma are typically diagnosed with 2D Fundus and 2D US [33],
occasionally showing an intra-ocular tumor invasion of the eye. However, confirmation of
tumor extent and diagnosis before treatment often requires patients to undergo structural
imaging modalities to look for calcifications and second recurrent malignancies (CT or MRI),
being the former more invasive than the latter due to ionizing radiation and less recommended
for such a task [14, 37], and the evaluation of all these information sources simultaneously by
multiple experts (e.g. ophthalmologist, oncologist and radiologist).
General methods for deciding the treatment strategy are based on the evaluation of the tumor
size and location. Big tumors occupying most of the VH cavity may suggest more aggressive
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procedures, such as enucleation. However, smaller tumors ( < 6mm) may allow for more
conservative approaches where the eye can be treated with minimally invasive techniques.
In this category we would find brachytherapy, intra-arterial chemotherapy or intravenous
chemoreduction [33, 36, 43]. For the particular case of retinoblastoma, a high percentage is
initially treated with intra-arterial chemotherapy, moving towards other techniques in case
the first treatment strategies do not evolve as desired. In this context, characterizing the
tumor with accurate measures of the size would pose a significant step towards better decision
making before treatment. Current techniques based on Fundus and US show good results
as first screening of the disease, and they continue to be relevant for consecutive follow ups,
however, they may fail to offer a broader picture about second recurrent malignancies, or even
to evaluate the extent of the pathology at 3-dimensional level, a field where 3D MRI is salient
[37].
In the past years, 3D MRI has gained interest for imaging of eye tumors due to its remarkable
soft tissue intensity contrast and its resolution [39], to the point of being the image modality
of preference for intravenous chemoreduction (intravitreal needles) or proton beam therapy
planning [33]. Nonetheless, Fundus exploration and evaluation remains the key step during
treatment, as it provides micrometric information of the tumor extent. Small structures, such
as the optic disc, the macula and the location of small tumors, can sometimes only be detected
via Fundus and are critical for proper patient treatment planning and follow-up. Needless
to say, having a reliable way to fuse multiple image modalities (e.g. MRI and Fundus) would
provide clinicians with the missing part of information in the same evaluating context, easing
collaboration between experts before eye treatment and thus, supporting therapy [94].
4.2 Related work
4.2.1 Fundus Photography and Fusion
In Fundus imaging, detection and segmentation of retinal anatomical regions are key for
evaluating eye diseases (e.g. Glaucoma, Diabetic Retinopathy or AMD) [11]. In the last decade,
an intense effort has been devoted towards automatizing the process of segmentation, showing
a great success in early detection of eye diseases. However, these techniques for optic disc
and fovea segmentation rely on the analysis of Fundus images where both landmarks are
still visible [128, 129]. In pathological Fundus images it is often the case that landmarks are
occluded by the growing tumor inside the eye, thus preventing their detection (see Fig. 4.1-D).
In a different narrow category within the field of eye imaging we would find fusion of Fundus
and MRI. The first attempt to ever connect them was presented by De Zanet et al. [94],
with whom we proposed a method to combine healthy MRI and Fundus by using common
anatomical landmarks. His approach introduced a new method for landmark detection based
on FRST and landmark circularity to combine both modalities. Despite the success of the
fusion at a qualitative level, we were unable to fully validate the proposed technique, and
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only assessed the fusion in a small subset of healthy patients, leaving the door open to more
sophisticated fusion schemes where additional landmarks (such as the tumor itself) could be
used to extract quantitative results.
4.2.2 Eye structure segmentation in 3D MRI
To date, efforts for manual delineation of the eye tumor and structures in MRI would require
hours of tedious labeling by experts, regardless of the tumor shape and size (Fig. 4.1 A-C). As
such, there exists a particular interest for automating this process and to provide a consistent
and accurate tumor segmentation specific to the patient.
Current techniques for eye segmentation in the MRI consider the use of parametric models
to segment eye structures (e.g. eye lens and vitreous humor) but assume the eyeball to be
close to spherical. Among the most extended methods we have OCTOPUS [49], which relies
on CT imaging to semi-automatically segment ocular regions with an elliptical model. Most of
these techniques allow a coarse segmentation of different eye parts and play an important
role in tumor treatment for uveal melanoma [42], however, they are tedious and prone to
user-specific errors. More recently, ASM [66, 67] have been used to more precisely delineate
these same eye regions using T1w VIBE MR images [2] and CT [99]. Unfortunately, these
techniques only address the eye segmentation problem in volumetric image data, and none
explicitly tackles the segmentation of malignant tissue. Only the recent work in [22] seeks eye
tumor segmentation with a reduced 16-patient dataset.
A) B)
C) D)
T1w VIBE T2w
Tumor Delineation Fundus Tumor Segmentation
Figure 4.1 – Multi-modal Imaging of Retinoblastomas (A)-(B) Detail of 3D T1w VIBE & T2w
MRI (C) Delineation of eye tumor in both MRI sequences (D) Fundus of the eye and retinoblas-
toma manual segmentation (dotted line).
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In this chapter, we introduce a method to combine the automatic eye tumor segmentation
framework presented in Chapter 3, capable of delineating healthy and pathological structures
in the MRI and manually segmented Fundus images, and use common anatomical landmarks
and regions to fuse the two image modalities. The method is described as a combination of a
PEM, that enables the automatic segmentation of different regions of the eyes (e.g. lens, sclera,
cornea, vitreous humor), followed by a classification step where pathological areas inside the
eye in the 3D MRI are identified. To carry out the tumor segmentation in the MRI, we utilize
the EPSF presented in [22], derived from the PEM, that provide a rich characterization of the
pathological tissue, even when small training data is available.
4.3 Methods
Here we describe the method to delineate ocular tumors and structures using a PEM for
multi-sequence 3D MRI segmentation, then the automatic segmentation of retinoblastoma in
Fundus. Finally, the last part explains the fusion of both image modalities and the benefits of
the landmark-based registration to combine Fundus and MRI.
4.3.1 Segmentation of Eye structures and tumor in MRI
The MRI volumes are first pre-processed in the same fashion as in Chapter 3. That is, by
automatically aligning both the T1w VIBE and T2w using a rigid translation and rotation,
followed by a cropping of the VOI corresponding to the pathological eye [94]. In this process,
the center of the VH, the center of the lens and the optic nerve location are found. We then
equalize all images for both sequences using the techniques explained in [110] and prepare
the volumes for the automatic segmentation of eye structures and tumor [22]. A complete
overview of the pipeline presented in this section can be seen in Fig. 4.2.
Automatic Eye
Segmentation
Registration Eye Patient-SpecificFeatures (EPSF)
Standard 
Features (STD) Classification
Training + Testing
(CNN - DeepMedic)
Graph-Cut
Refinement
3D MRI Volumes
2D Fundus
Manual Delineation
Landmarks + Tumor
1) Projection 3D MRI to 2D plane
2) Registration
3) Fusion 3D MRI & Fundus
Smoothing
B) Segmentation of Eye Structures and Tumor
C) Fundus Image Segmentation
D) Back-projection: Fusing MRI & Fundus
Figure 4.2 – Multi-modal fusion framework: Image features extracted from T1w and T2w MRI
volumes are combined with EPSF and STD features that integrate Vitreous Humor (VH), eye
lens shape and position information, as well as likelihood of tumor locations. These features
are used to train a classifier (CNN DeepMedic) and are later refined, in a similar fashion as the
Fundus classifier. A-C) summarizes the steps to perform the fusion.
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CNN Classification: the likelihood prior provides the probability P for every voxel i within
the VOI to belong to either healthy or pathological tissue Yi = {0,1}. In this work, we leverage
a 3D CNN presented in [119], known as DeepMedic, to train an 11-layer deep network for
performing classification. The input considers 9 different channels, including the two acquired
sequences T1w VIBE and T2w, the A-T1w, the average 6 nearest neighbors of the T1w, T2w
and A-T1w, and the EPSF, namely, the lens distance map and the VH distance map, which
were obtained during the automatic segmentation of the eye, and the pathological patient
likelihood prior, in the form of fti = 1N
∑N
n1 Yi , where N is the total number of volumes in the
training set (in this case, 32). The configuration is a state-of-the art CNN consisting on a
combination of eight 33-sized kernels, with three fully connected layers at the end, leveraging
training data augmentations with reflections over the x, y and z axis. It uses dropout [126] with
50% rate at the final layer, Batch normalization [127], which accelerates training’s convergence
and is also related to the activation of neurons across a whole batch. The rest of the parameters
were kept equal to the original configuration [119].
Refinement: we want to support similarity between neighboring pixels for the T1w and T2w,
therefore we model the smoothness prior as
P (Yi ,Y j )=α ·e
− 1
2σ2T1
(T i1−T j1 )2 + (1−α) ·e
− 1
2σ2T2
(T i2−T j2 )2
, (4.1)
where T i1 is the intensity value at voxel i of the T1w VIBE volume (and similarly for T
i
2 ),α ∈ (0,1)
is a bias term to model balance between T1w and T2w and (σ2T1 ,σ
2
T2
) are the voxel intensity
variances of tumor locations in T1 and T2.
4.3.2 Fundus Image Segmentation
The manual segmentation of Fundus contains the delineation of the retinoblastoma tumor
shape as well as the the position of the optic disc, a bright circular shape of approximately
2mm that indicates the connection of the retina with the optic nerve towards the brain. This
information is required for fusing both images image modalities, as will be shown in section
4.3.3.
In this work we will rely on the manual delineation of the retinoblastoma and the center of
the optic disc, a task that can be achieved in a few seconds when performed by an expert
ophthalmologist.
4.3.3 Back-projection: Fusing MRI and Fundus
The automatic multi-modal fusion of the Fundus image and the MRI is performed once tumor
segmentation is finished for all image modalities. From the MRI we obtain the CNN automatic
segmentation of the retinoblastoma as ∪Yˆi ,k = 1 ∈ Xk , as well as the position of the optic disc
(pOD−MRI k ), the lens center (pLC−MRI k ) and the cornea peak (pC P−MRI k ). A set of landmarks
that were obtained by combining the process described in section 4.3.1 using the FRST, and
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the prior knowledge about the 3D eye anatomy for all k = {1, .., N } patients.
T1w VIBET2w T2w T1w VIBE
GT
CNN
Fundus
Prior
Fundus
Prior
Figure 4.3 – Fundus Probability Prior Map: Two examples of the Fundus Prior probability
map obtained in section 5.2. The light blue areas are the result of the automatic segmentation
in the 3D MRI. The cones do not always represent the whole tumor area as the Fundus camera
field of view is rather limited.
From the Fundus image Fk , we obtain the location of the optic disc (pOD−Fundusk ), whenever
the tumor is not covering the area of interest, and the retinoblastoma tumor shape, either
manual or automatically segmented as ∪Yˆ j ,k = 1 ∈ Fk , at every particular pixel j . At this
point, registration of the Fundus to the tumor and retina surface in the MRI is performed in
three consecutive steps: First, we project the 3D tumor MRI shape obtained as described in
section 4.3.1 into a 2D plane, second, we use the location of the optic disc and the tumor shape
to register both images using ICP and finally we connect the information across modalities,
exporting the benefits of 3D MRI to the Fundus and vice versa. An overview of the whole
process can be observed in Fig. 4.4.
Projection of 3D MRI into a 2D plane
Let Xk represent the MRI volume for patient k, we then compute the normalized optical axis
vector,
vˆn−O Ak =
pC P−MRIk −pLC−MRIk∥∥pC P−MRIk −pLC−MRIk∥∥ , (4.2)
from there, we define the camera position,
pcamk = pLC−MRIk + vˆn−O Ak ∗dL−MRIk , (4.3)
as the central point from where the 2D plane, Qk , is to be constructed, and dL−MRI = 70mm is
an arbitrary distance from the cornea peak equal to all patients. From here, we extract nxk and
nyk as the cross product of vˆn−O Ak , providing the angles to define the 2D camera plane. Now,
let FMRIk define a 2D virtual projection with size xFMRIk = [−120,120] and yFMRIk = [−120,120]
and map its coordinates in the 2D camera plane,
Qcamk = FMRIk ∗ [nxk ,nyk ]+pcamk , (4.4)
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A) B)
C) D)
Figure 4.4 – Back-projection pipeline: A) Projection of the segmented tumor on the virtual
plane FMRI . B) 3D representation of the projection for every voxel i onto the surface repre-
sented by the plane FMRI . The red-stripped line represents the projection of the OD. The
green points represent the projection of the remaining voxels. C) Reconstruction of the tumor
shape prior to back-projection. Every vertex is mapped onto the plane represented in B). D)
Results after rigid ICP registration. Green-dashed line: Retinoblastoma Fundus Segmentation
GT, blue-dashed line: MRI CNN segmentation results after applying scaling factor gk .
Furthermore, we extract the 3D surface representing the tumor that we segmented in sec-
tion 4.3.1 using the marching cubes algorithm [108], and obtain the vertex that conform the
tumor shape. At this point, we project each of the vertices pi ,k into Qcamk , by first obtaining
the vector that maps the vertex into the plane (Eq. 4.5) and the point pQi ,k (Eq. 4.6),
vpi ,k = pi ,k −pLC−MRIk , (4.5)
pQi ,k =
pcamk − (pLC−MRIk × vˆn−O Ak )
vpi ,k × vˆn−O Ak
∗ vpi ,k +pLC−MRIk (4.6)
Once the projection is achieved for all pQi ,k and volumes, we connect them by using a Delaunay
triangulation [130] and extract the external perimeter of the shape, thus outlining the final
tumor shape in the projected FMRIk . This shape is to be registered to the original Fundus in
the next section 4.3.3 and is represented in Fig. 4.4-C).
Registration with ICP
We process the two different shapes. The original Fundus, Fk , and the FMRIk . To this goal, we
first flip over the x and y axis the FMRIk , as to compensate for the pin-hole back-projection
effect we induced in the previous Section 4.3.3. Furthermore, we smooth the curvature of the
tumor shape, applying a gaussian smoothing of σ= 3, and compensate for the difference in
area applying a multiplication factor gk =
√
aFk
aFMRIk
, where aFk and aFMRIk correspond to the
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area covered by the tumor region in both image modalities. We wish to simplify the problem
based on the assumption that the two shapes should be deemed similar to one another. Then,
we use ICP, as presented in [131] in order to co-register both image modalities and we store
the matrix transformation MMRI as well as the translation TMRI ,
Fk ≈ IC P (gk ∗FMRIk ), (4.7)
Fk ≈MMRI k ∗ (gk ∗FMRIk )+TMRI k , (4.8)
A) B) C)
Figure 4.5 – MRI projection into Fundus: A) Back-projection of a voxel subset from the MRI
volume X . These points follow the projection and registration process and are mapped
within the area delineated by the Fundus segmentation. B) Gaussian smoothing and fi
rounding for easier representation of the tumor shape. C) Detail of the superposition of
the Fundusretinoblastoma GT (blue dashed) and the projection of the automatic MRI tumor
segmentation.
Connecting MRI and Fundus segmentation
Once the mapping that connects a voxel i ∈ Yi = {1} in the volume Xk with its location in Fi ,k
is defined, we can now write the transformation as
Fk =MMRI k ∗ (gk ∗
∑
i
pQi ,k )+TMRI k , i = {1, ..., s} (4.9)
and use it to evaluate whether ∪Yˆi = 1 is present inside the tumor shape in the Fundus image
Fk , or, else, it is outside the shape. That is, we use this information to evaluate whether a voxel
j would be mapped inside the 2D Fundus and was, indeed, labeled as Y j = 0 during the CNN
segmentation in the MRI. This offers a new method for evaluating the performance of the
segmentation based on the alternate connected image modality.
4.4 Results
4.4.1 Evaluating the fusion of MRI and Fundus Image Photography
For validating the fusion between Fundus and MRI we use the DSC between the segmented
retinoblastoma on the Fundus as compared to the adjusted projection from the MRI, for both
the 3D MRI CNN and the GT.
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The results of the DSC for the projection of the 3D MRI CNN segmentation as compared to
the manual segmentation performed by an expert reached 87.95±6.98%. When compared to
the GT, we reached a total 89.56±4.98%. These results indicate that even for the best possible
fitting, offered by the manual segmentation of both images modalities, the results would not
surpass ≈ 90% DSC.
4.5 Conclusion
We have presented a method for the multimodal fusion of MRI and Fundus for images from
pathological patients. Our method considers using common anatomical landmarks present in
both image modalities (such as the optic disc and the tumor itself) in order to perform this
task. The fusion relies on the accurate segmentation of MRI and Fundus prior to the presented
landmark-based registration using ICP.
Unlike other methods, such as intensity-based techniques for image registration using mutual
information [132, 133], we focus on fitting the two groups of landmarks not only because
the tumor intensity would be very similar to that of the surrounding voxels representing the
sclera and the choroid, but also because MRI may contain artefacts and/or noise that could
affect the final registration results. Furthermore, the difference in scale due to the optics of
the Fundus camera would also pose an added level of complexity to the problem. In the next
chapter we propose two different applications for the fusion and evaluate the quality of the
method, toward improving multimodal eye tumor analysis.
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Fusion of MRI and Fundus Image
Photography : Applications for
treatment of ocular tumors
The previous chapter established the foundations for the multimodal fusion of MRI and
Fundus. In this chapter we will focus our efforts on retinoblastoma, the most common ocular
tumor in children [37]. Here, we present two different applications for the fusion and evaluate
the quality of the results. First, we introduce a (i) method for improving the quality of the
delineation of the 3D MRI based on the back-projection of 2D Fundus, in a process that we
call Fundus Prior and second, (ii) we propose a method for transfering the 3D rich information
from the MRI tumor segmentation to the 2D Fundus image in the form Topographic Fundus
Maps.
5.1 Dataset
The dataset used in this work includes two different image modalities, 3D MRI and Fundus
retinal photography. The MRI dataset is formed by 32 pathological 3D volumes of patients
with endophytic retinoblastoma. The volumes represent a section of the head of the patient,
including both eyes and the optic nerve. MRI was performed in a 3T Siemens Verio (Siemens,
Erlangen, Germany), with a surface head coil of 32 channels. The images are gadolinium
enhanced T1w VIBE (repetition time/echo time, 20/3.91 ms; flip angle, 12°) acquired at three
different spatial resolutions:0.416×0.416×0.399mm3, 0.480×0.480×0.499mm3 and 0.30×
0.30×0.31mm3 and T2w (repetition time/echo time, 1000/131 ms; flip angle, 120°) with a
resolution of 0.453×0.453×0.459mm3 of and 0.27×0.27×0.31mm3. Acquisition of the MRI
volumes was done under general anesthesia.
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Fundus sequences have been acquired using a RetCam (Clarity Medical Systems, Pleasanton
(CA), United States), a camera with interchangeable frontal lens that is applied directly on the
cornea of the anesthetized patients and is specific for pediatric retina.
All patient information in our study was anonymized and de-identified by physicians prior to
our analysis, and the study was approved by the Cantonal Research Ethics Committee of Vaud.
For each eye, the tumors were manually delineated by an expert radiologist. We use these
manual segmentations as ground truth for quantitative comparisons. The corresponding
Fundus image were selected following the criteria of the clinical institution. That is, the
Fundus was acquired within 3-7 days before or after the date of the MRI scan, thus ensuring
minor to non-existing variations in the size of the tumor. The retinoblastoma and the most
relevant landmarks in the Fundus were delineated by an expert ophthalmologist.
5.2 Improving 3D MRI delineation via Fundus Prior
5.2.1 Motivation
Automatic segmentation of ocular tumors on the MRI has been already covered in this thesis
in chapters 2 and 3, however, the results of the segmentation often regarded artifacts and
healthy areas of the eyes as tumors, both due to MRI noise and to the uncertainty while doing
classification. Furthermore, the amount of patients that were used in these experiments was
rather low (≈ 32 MRI volumes), eventually reducing the quality of the classification scheme.
In a sense, there is a clear room for improvement given a bigger dataset and additional
retinoblastoma patient segmentations.
In here, we propose a technique to improve the segmentation results beyond the fine-tuning
offered by the graph-cut optimization refinement from section 4.3.1. The use of Fundus
images in order to improve the quality of the segmentation results in the MRI. Our hypothesis
is that the local accuracy of the submilimetric tissue information from the Fundus tumor
segmentation will benefit the delineation on the MRI, removing potential spureous false
positives outside the tumor area for small cancers. Section 5.2.2 covers the methods required
in order to obtain this Fundus Prior information.
5.2.2 Methods
We start once the fusion scheme proposed in chapter 4 is completed. From there, we use
the MRI segmentation after the DeepMedic CNN classification and the Graph-Cut refinement
to generate a probability map, F Pi ,k from the 3D volume Xk which takes into consideration
every voxel i in the volume and is constructed as,
F Pi ,k
{
HD(F (Xi ,k )), F Pi ,k =∈ F ∪Yi
0, other wi se
(5.1)
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where HD and F (Xi ,k ) is the projection of the MRI voxel into the Fundus. Whenever voxel i is
mapped inside the Fundus retinoblastoma segmentation, a value of equal to the HD will be
assigned to this specific voxel, a value of 0 will be assigned otherwise, as shown in the previous
equation 5.1. The final outcome of this process is a 3D map of the tumor, with a rather conic
shape, that could be utilized for improving delineation of the cancer in the MRI, removing
external misclassified regions within the eyeball. A more detailed graphical explanation can
be found in Fig. 4.3. In the section 5.2.3 we further develop a set of experiments to compare
delineation results.
5.2.3 Results and conclusion
This section introduces the MRI tumor segmentation results, evaluating the CNN network
with and without the contribution of the Fundus Prior.
Contribution of Fundus Prior to the Segmentation of Eye tumors in 3D MRI
We start by evaluating the method presented in section 4.3.1 for 3D MRI tumor segmentation.
We use the PEM proposed in [22], trained on 16 pathological eyes, in order to automatically
segment the eye ball, including the regions of the sclera, the cornea, the VH and the lens. We
then use the EPSF to improve the quality of the tumor classification, as they provide rich spatial
and intensity information for the different eye regions in the MRI volume. To conclude, we set
up the minimum number of iterations as to reach convergence to 35 epochs. A qualitative
evaluation of the results can be seen in Fig. 5.1.
0.48x0.48x0.499 mm 0.416x0.416x0.399 mm 0.48x0.48x0.499 mm 0.30x0.30x0.310 mm
A)
B)
Figure 5.1 – 3D MRI Tumor Segmentation : A) T1w VIBE and B) T2w segmentation examples
for patients with different image resolution, ranging from≈ 0.5mm almost isotropic resolution
to ≈ 0.4mm and ≈ 0.3mm. Segmentation results for smaller tumor structures are consistently
worse. Minor variations in the segmentation cause a high impact in the DSC.
Once this task is finished, we measure the overlap between the manual delineation and
the results of the classification by computing the DSC in a 16-fold cross-validation on the
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32 endopythic retinoblastoma MRI volumes (Table 5.1). That is, we train our CNN on 30
patients and test on the remaining 2. Furthermore, we evaluate the contribution of using the
back-projection technique from section 5.2, represented in Fig. 4.3.
We post-process the resulting 3D MRI tumor segmentation after GC utilizing the FP as a mask
for improving the segmentation of small tumors (< 1k voxels), reducing the misclassification
outside the tumor region. The goal is to use the fusion to leverage the micrometric information
provided by the Fundus, and to improve the final segmentation results in the MRI (with a
resolution in the order of the milimeters). The parameters we defined in order to achieve
these results are α= 0.3 and β= 0.7 for the automatic refinement of the 3D MRI classification.
Moreover, we test two different setups, Hard and Soft FP, corresponding to binary or smoothed
masking of the tumor region respectively. The Gaussian smoothing for the Soft FP is set to
σ= 8voxel s. Table 5.1 contains information from the different configurations and the DSC
for every step. The complete list of results can be seen in Fig. 5.2.
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Figure 5.2 – DSC vs. tumor size : results for the different techniques applied to the classifica-
tion output, including: The baseline CNN EPSF, CNN EPSF after GC, CNN EPSF+GC + Hard
Fundus Prior and CNN EPSF + GC + Soft Fundus Prior.
To conclude, we compute an additional experiment. We re-train the DeepMedic 3D CNN
implementation including the FP as an additional feature map. The goal here is to evaluate
the contribution of the FP information during the 3D MRI CNN training. Given that the FP is
not always contributing to improve the quality of the segmentation due to the Fundus field of
view, we use a uniform probability map as the channel for cases where tumors are < 1k voxels.
The results of this experiment can be seen in Table 5.1 1.
The results show a slight average contribution of the Fundus towards improving the quality of
the segmentation results in the MRI. However, the contribution is marginal.
1The hardware requiered to achieve these results can be seen in Experiments were computed on ¦: Macbook
Pro Intel-Core™ i7 16GB - 2,5 GHZ & †: Intel-Core™ i7 6700 32GB with Nvidia GTX Titan X®
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MRI CNN MRI CNN + FP
DSC [%] 72.42±15.82% 70.54±18.51%
DSC (GC) [%] 73.85±15.64% N.A.
DSC (GC) + FP (Hard) [%] 72.54±17.19% N.A.
DSC (GC) + FP (Soft) [%] 74.05±14.15% N.A.
Training time [min] 621.39±18.48 681.7±4.54
Table 5.1 – Tumor segmentation before and after FP : DSC performance for MRI tumor seg-
mentation before and after graph-cut (GC) combining both Hard and Soft FP. The Hausdorff
Distance (HD) after GC and Soft FP is also presented.
5.3 Tumor characterization and Topographic Fundus Mapping
5.3.1 Motivation
In addition to the minimal improvements to the automatic segmentation of ocular tumors
in either Fundus or MRI, the fusion can be utilized to represent both image modalities in a
common reference shape. The goal of Topographic Fundus Mapping is to be able to connect
and transfer 3D milimetric and 2D micrometric information and knowledge accross modalities
and clinical specialists (e.g. radiologist, ophthalmologist, ...).
Every clinician has a preferred image modality of choice to evaluate ocular tumors and to
decide on the treatment to follow, nevertheless, the information of the non-preferred image
modalities may bring interesting discussions to the table, such as variations on the final treat-
ment strategy and a better tracking of evolution of the disease during follow-up. Furthermore,
the possibility of transferring information from 2D to 3D may allow for new unprecedented
ways to confirm the tumor extent faster and better than during single modality evaluation
techniques.
5.3.2 Methods
The second application presented in this chapter is to introduce rich 3D tumor shape informa-
tion into the 2D Fundus after registration. Back-projection, presented in chapter 4, allows MRI
to Fundus support during evaluation, with an estimation of the tumor size (in mm3) as well
as a new volumetric characterization of the tumor, overlapped over the Fundus tumor shape,
and identified as Topographic Fundus Mapping (TFM). TFM are constructed by leveraging
the VH distance map computed during the automatic segmentation of the eye in the MRI (in
Section 4.3.1) with the registration scheme proposed in Section 4.3.3.
For every voxel i ∈∪Yi in the volume X we perform the back-projection F (Xi ) and evaluate the
presence of the projected voxel within the area delineated by∪F j = 1, where∪F j = 1 represents
the location of the tumor in the retinal image, a region which is either manually segmented
or delineated using the method presented in section 4.3.2. ∪F (Xi ) ∈ ∪F j ,Y j = 1 represents
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the sparse distribution of points on the Fundus image. An example of this point cloud can be
seen in Fig. 4.5-A). Now, every projected point contains the feature value fi corresponding to
the distance to the surface of the retina, that is, the distance to the segmentation of the VH
boundary. From here, we simplify the problem by computing [∪F (Xi )] and perform a Gaussian
smoothing G(x) of σ= 10, to regularize the region of the tumor (see Fig 4.5-B). We also store
the F99.8% percentile representing the maximum fi , corresponding to the highest distance,
and use these values to restore the original height, Hor i g , where we define gT F M = F99.8%max(G( fi ))
to compensate for the difference in scale after the gaussian smoothing.
Finally, in order to be able to retrieve the MRI scaling factor for the TFM, we compute the
distance between two points separated 20 voxels in the 3D MRI sagittal plane. The Euclidean
distance between both projections on the Fundus image allows for the estimation of the
physical scaling factor that connects pixels to measures in mm.
A) B) C)
4
3
2
1
[mm]
[pixels]
Figure 5.3 – Topographic Fundus Mapping: A) Gaussian smoothing of the back-projected
point cloud with compensated VH distance information. B) Overlapping TFM curves over
Fundus image. The different numbers indicate distance (in mm) from the retinal wall. C) 3D
representation by means of texture mapping of the Fundus over the surface defined by the
tumor shape.
At this point, we are able to provide topographic and volumetric information of the Fundus
image Fk by means of the landmark-based registration proposed in the Section 4.3.3. In Fig. 5.3
we have an example of the resulting TFM and the projection of the Fundus photography over
the artificially generated surface.
5.3.3 Results and conclusion
Here we demonstrate that the presented registration technique allows for 3D MRI rich tumor
information to be transferred to the Fundus image, opening the door to more complex multi-
modal characterization of the tumor in 2D and 3D.
Topographic Fundus Mapping (TFM)
For validating the fusion between Fundus and MRI we use two different techniques. The first
one was presented in the previous chapter and consisted on the quantitative DSC evaluation
between the segmented retinoblastoma on the Fundus as compared to the adjusted projection
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Table 5.2 – Tumor apex in MRI measured by clinician vs. Distance Map (ASM Segmenta-
tion) and Fundus projection apex : This table indicates the difference between the distance
measured by an expert clinician to indicate the tumor apex (required for brachytherapy) and
the estimated apex obtained via the ASM and the Fundus back-projection.
Distance Map
(Error) [mm]
Fundus Projection
(Error) [mm]
Manual Measure
-Clinician-
0.523±0.431 0.690±0.547
p-value 1.35e-5 3.53e-3
from the MRI, for both the 3D MRI CNN and the GT, see Section 4.4.1. The second part of
the evaluation consists on measuring the quality of the surface representation given by the
TFM. To do so, we a) compute the distance between the apex of the tumor to the normal of
the retinal wall as compared to the results in the 3D projection and b) perform a qualitative
evaluation of the results.
Both a qualitative and quantitative evaluation are conducted for the TFM. A subset of these
can be observed in Fig. 5.4. The remainder of this article focuses on the comparison between
the i) GT distance measured by a clinician, ii) the apex distance manually extracted from the
MRI segmentation (VH Distance Map), the and Fundus fusion reconstruction at the 99.8%
percentile. Table 5.2 shows the results between all three measures. We can observe that the
difference between the two errors is comparable, and statistically significant for both cases,
being a little over the resolution threshold.
Figure 5.4 – Evaluation of Topographic Fundus mapping : A few examples of the multi-modal
fusion of Fundus and MRI. We leverage the 3-dimensional information from the MRI in order
to give a 3D context to the Fundus. TFMs maps are generated from the point projection on
the left side and connected to the Fundus image on the right for 6 patients. These new images
have a 3-dimensional shape and navigation allows a better understanding of the disease.
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5.4 Discussion
In here, we have introduced a new method for the registration and fusion of 3D MRI and 2D
Fundus. The technique leverages the segmentation of retinoblastoma in Fundus by manual
means, as well as the automatic segmentation of the eye tumor in the 3D MRI for achieving
this goal. This is, to the best of our knowledge, the first attempt to ever fuse such pathological
image modalities succesfully. The whole pipeline attempts to segment both image modalities
independently to later use common anatomical landmarks, such as the optic disc and the
tumor itself, to properly connect the microscopic world representation, obtained via Fundus
imaging, with the macroscopic MRI representation.
The clinical implications of this work are unique in its proposition to combine one of the
most useful image modality for radiologists (MRI) and the requirements for ophthalmologists
(Fundus), towards confirmation of diagnosis and treatment for patients with retinoblastoma.
This fusion will pave the way for clinicians to share their evaluation tools in a simultaneous way,
contributing to the discussion of results in a common multi-modal ground, where new angles
and evidences can be considered. Furthermore, the connection between image modalities
will allow for a better follow-up of the disease, where succesive Fundus acquisition could be
used to evaluate the impact of a certain treatment on the size of the tumor, without the need
of continuous MRI scanning and, thus, reducing operational costs.
From an analysis point of view, interesting are the comparison between the fusion of both
image modalities and the difference in tumor shapes. This situation is driven mainly by two
factors. The first one is the geometric distortion that appears whenever we evaluate voxels
between the AS and the center of the eye whose trajectory differs< 30° to that of the optical axis
(as expressed in section 4.3.3). These projections tend to be more distorted than points closer
to the posterior part of the eye, where both the optic nerve and OD are located. Furthermore,
the difference in scale and resolution between Fundus and MRI also affects negatively to the
shape. It is often the case that clinicians may commit delineation mistakes when it comes to
evaluate tumors in the MRI, not only because the tumor intensity is very similar to that of the
surrounding voxels representing the sclera and the choroid, but also because MRI may contain
artefacts and noise. One of the main purposes of the presented work is to clean these artifacts
and to be able to obtain an accurate representation of the disease, reinforcing its accuracy
at local level. Albeit the limitations of geometric distortion during the MRI projection, the
fusion represents a clear support for clinicians during the diagnosis evaluation and follow-up
of the tumor and, even if there exists minor geometric deformations, longitudinal studies of
the same patient would be able to cope with the temporal variation in tumor size and monitor
their variation. Moreover, we highlight the contribution of simplifying the image registration
process with common anatomical landmarks instead of the usual intensity-based methods
combined with mutual information. By doing so, we reduce the computational burden and
rely on the quality of the tumor shape rather than on confusing retinal intensities for fitting
the new model. The additive problem of a varying scaling factor connecting the MRI and
Fundus, combined with a difficulty to distinguish the mussels behind the sclera discouraged
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us from performing these experiments. In future work it would be desirable to get a wider
representation of the retina region by using Fundus mosaicking, as the combination of images
would provide a more complete representation of the eye and the pathologies therein.
With regards to the limitations we encountered while working with the fusion, we may highlight
the problems for properly representing massive tumors (10k < voxels) using Fundus imaging.
In these cases, tumors grow inside/outside the eyeball and they become a natural barrier to
capture the interior part of the eye with retinal cameras, leaving 3D MRI scans as the best
option to represent the tumor in its completion. In these particular cases, the treatment tends
to be a bit more aggressive and enucleation is often required. The presented work would be
more relevant to those small-sized tumors where decision for treatment falls in a grey area
between side effects and patient prognosis.
Multi-modal fusion is one of the biggest challenges in ophthalmology and the presented work
introduces a key connection for combining Fundus and MRI. The common anatomical land-
marks that we find in these modalities will pave the way towards having not only Fundus and
MRI data, but also including OCT information during the evaluation of retinoblastoma before
treatment. Current devices for acquiring OCT images already incorporate the acquisition
of Fundus images, thus, it would be a composition very much in line with the future ocular
tumor research. One of the key problems in pediatric oncology research for ocular tumors is
the low amount of dataset for proper evaluation of the disease when different treatments are
considered. Multi-modality is a solution to leverage the knowledge obtained from multiple
information sources, and to better understand the evolution of the disease, towards precision
and patient-specific medicine.
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Conclusion
Summary
In this thesis I have presented an ensemble of image processing techniques to improve current
methods for multimodal imaging in ophthalmology, focusing on MRI and later on Fundus
imaging to support clinicians during treatment planning and follow-up of ocular tumors.
The first part of the manuscript covered the analysis and representation of the eye at a macro-
structural level with the evaluation of the 3D MRI, a technique that was routinely used to
investigate the spread of tumor in the optic nerve and/or through the eye wall [3] has slowly
transitioned towards the evaluation of the tumor extent via multi-sequence MRI analysis (T1w
VIBE and T2w) [39]. Our efforts have focused on the analysis of eye populations and the use of
statistical modeling techniques to ease the process of characterizing the eye. To this end, we
used Active Shape Models (ASM) to model the regions of the sclera, the cornea, the vitreous
humor and the lens, and created a framework for the fully automatic segmentation of the eye
in the T1w VIBE MRI in children. The accuracy and robustness of the presented scheme for
delineating healthy eyes in T1w VIBE allowed for the segmentation, not only of such regions
in healthy children eyes, but also the healthy eye structures in pathological patients with
retinoblastoma. The complete method and results are introduced in chapter 2.
The results of automatic eye segmentation alone were not sufficient for the proper charac-
terization of ocular tumors in multi-sequence MRI, a long sought goal prior to treatment
planning for evaluating the malignancy. The previous work in Chapter 2 served as a method
for segmenting healthy regions in pathological MRI, and defined an advantageous starting
point for using general purpose machine learning techniques to classify the tumor inside
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the eyeball. In Chapter 3, we considered the use of a dataset of pathological patients with
tumors to build a new ASM to segment the eye in 3D T1w VIBE. Unlike other methods for brain
segmentation, this method utilized pathological patients instead for training the statistical
model, achieving better segmentation results (see section 3.3.1). This particular result could be
justified by De Graaf et al. [96], who demonstrated that, on average, retinoblastoma eyes were
smaller than normal eyes and that there was a negative correlation between tumor growth
and eye volume size. Then, we registered the T1w VIBE to the T2w MRI and introduced a
set of specific features called Eye Patient-Specific Features (EPSF) to characterize the shape,
location and likelihood of the tumor. The outcome of this approach was the improvement of
the segmentation of small ocular tumors and the simplification of the classification problem
thanks to the rich spatial and intensity information. Furthermore, again we put special atten-
tion to the automatization of the whole process, always looking for easy methods to support
clinicians in the field of ocular tumor research.
Finally, I would like to close this summary with a contribution that we started in collaboration
with De Zanet et al. in [94], a method for the multimodal fusion of MRI and Fundus image
photography. At first glance, the reader may notice the significant difference in scale and
resolution between both image modalities, and thinking of a proper multimodal fusion is
an idea surrounded by numerous challenges. In [94], we estimated the location of the fovea,
the optic disc and the optic axis in the Fundus, as well as the automatic segmentation of the
vitreous humor of the eye to achieve a multimodal fusion of healthy patient eyes. However, we
could not validate the results and we were still far from our goal of using fusion to support the
clinician, especially during evalution of the tumor extent and multi-modal confirmation of the
malignancy. To this end, this work introduces a new fusion method using common anatomical
landmarks and the tumor itself to register both MRI and Fundus in a precise landmark-based
fashion with ICP. Chapters 4 and 5 cover the proposed multimodal fusion of Fundus and
MRI scheme where a robust regristration is proporsed, able to cope with difference in scale,
variations in intensity and orientation between modalities. We furthermore used this new
fusion method for (i) improving the MRI segmentation results proposed in Chapter 3 and (ii)
provide Fundus image photography with 3D rich information from the MRI, creating a method
to transport 3D curvature to the image representing the 2D Fundus. The results presented
in Chapter 5 do support the hypothesis that the multimodal patient-specific representation
of the tumors will benefit clinicians from different backgrounds with this multimodal tool to
evaluate tumors simulatenously in MRI and Fundus during treatment planning and follow-up.
Perspectives and Future developments
In this work we demonstrated that we were able to provide clinicians with a set of image
processing tools to support their study and understanding of the pathology, its follow-up
and to support the decision treatment process, an asset specially useful when confronted
with agressive ocular tumors such as retinoblastoma. The applications that we presented to
automatically segment the eye structures and retinoblastoma in the MRI and its fusion with
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Fundus Image Photography will pave the way for similar approaches to other tumors such
as uveal melanoma, the most common eye tumor in adults [45]. Following these lines, we
received a project grant for the continuation of this thesis, towards translating these findings
to support adults patients with tumors in the uveal region.
Clinical Applications of the presented work. The navigation systems that we proposed with
the EyeModeler software in Annex B for exploring eye pathologies, and the possibility to use
these 3D computerized models for simulating and evaluating the disease will not only support
the clinician decision before treatment, but also allows sharing perspectives and thoughts
with fellow clinicians simultaneously. Moreover, the techniques that we applied to segment
the tumor at subresolution precission in chapter 3 will set the basis to further monitor the
evolution of such diseases in the form of longitudinal studies. In this direction, the analysis
of such data will shed some light towards refining the treatment strategies based on precise
indicators, such as the tumor location, size and even genetic factors. Last but not least, the
ability to model the disease combined with the organs wherein it is located would allow for an
easy transition towards the field of 3D printing eye patient-specific models for their analysis
(specially useful for brachytherapy treatment planning), bringing high precision medicine for
retinoblastoma one step closer to the clinician.
Towards alternative image modalities: OCT and US. The ever rising field of OCT imaging
has opened the door to deep analysis and detection of ocular pathologies such as DR and
AMD in the past [18, 19]. In the field of ocular tumors, though, its use remained limited, and
only a few articles in literature partially covered the use OCT as a screening protocol [134, 135].
Possibly, one of the most promising continuations of this work would be the adaptation of
the multimodal patient-specific eye model to include OCT image information in the pipeline.
This could be easily done via registration of the Fundus acquired during the OCT scanning
to the Fundus obtained with the pediatric Retcam. This contribution would finally connect
the macrostructural level of information given by the MRI with the microstructural level of
detail offered by OCT. Simultaneously, early diagnosis of retinoblastoma and blood flow
monitoring would open the door to real-time evaluation of chemotheraphy throughout the
eye, or even allow extremely precissed targeted cryotherapy, among many other different
challenges that would appear. Also, from a less ambitious point of view, the missing part of
this work covering the analysis of 2D and 3D US would also be beneficial for the clinicians,
and a very strong contribution to the multimodal patient-specific eye tool presented here. US
would bring a reliable non-invasive image modality between Fundus and MRI, not affected by
any magnetic field geometric distortion, presenting a trade-off between area of representation
and resolution quality. Other techniques presented in literature for 2D/3D US to MRI such as
the one presented by Cuadra et al. [98] would be an interesting continuation for this work, and
would contribute to better represent the eye accross different image modalities.
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Improving current models for delineation of the disease. Another of the limitations that
appeared during this thesis was the lack of big amounts of medical data for testing and training,
and the scarce annotations for the few we possesed. Retinoblastoma is a rare disease and as
such, it requires a strong collaboration with clinical institutions to obtain enough samples
as to claim generalization, regardless of the methodological contribution. In this context,
future collaborations with other centers or simply by releasing the developed techniques to
the scientific community would be an elegant move towards validating further discoveries.
EyeModeler Software. The presented techniques are based on medical imaging methods
on a constant evolution, thus, we designed our software in a modular fashion, enabling easy
interchangeable methods to be replaced whenever required. Among the future development
lines that we would consider as new modules for the EyeModeler software, we would have:
• The use of versatile machine learning techniques, similar to the ones employed in
chapters 3 and 4 with deep CNNs to improve the quality of the delineation at multiple
stages of the framework (e.g. the ASM building process, the delineation of ocular tumors
in both Fundus and MRI, ...).
• The contribution of multiple image modalities, such as stated before with US and OCT
for further improving the delineation and characterization of the disease.
• The longitudinal monitoring of the disease, evaluating differences between time points,
a especially interesting field of research towards deciding best treatment strategies based
on predictions and estimation of the cancer evolution.
• The use of multi-scale multi-sequence MRI for improving the final delineation of ocular
tumors in multiple image modalities. The current protocol for ocular tumor imaging
tries to account for the difference in resolution by taking multiple images of the same
ROI (the eye). In this particular context where multiple volume sequences representing
the same area would be available, we could investigate new method for the fusion of
multiple sequences towards super-resolution. This would not only improve the quality
of the images, but help to better delineate tumors and structures within the eyes.
In summary, the number of possible development lines is diverse and research can be con-
tinued in a variety of fields, either at clinical or methodological level. The objective though
will remain: to improve the quality of the work developed by clinicians and professionals in
healthcare, who will consciously drive this research towards new horizons, sharing their needs
and ideas and hopefully, taking benefit from the lines and contributions that came out of this
work.
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A
Atlas construction – Point-Based
Shape Variation Model – Active Shape
Model
This annex represents an addendum to the methods developed in chapter 2, further con-
tributing with an extended overview of the Atlas constructions, the PBSVM and the ASM
generation.
A.1 Atlas construction
The process to construct the atlas follows the lines of Frangi et al. [105]. However, we introduce
several minor modifications to the original method, such as a rigid volume pre-alignment
based on landmarks in the eye in the MRI [94], and a non-rigid free diffeomorphic demons reg-
istration algorithm [107] to transform the atlas into a Natural Coordinate System (NCS) [105].
We first align every MRI volume to a common reference coordinate system. We apply, to
each subject, a rigid pre-alignment using the landmarks from De Zanet et al. [94] based on 3D
FRST [136]. The center of the vitreous humor, the center of the lens and the position of the optic
disc help us to align all patients into a common reference space. Once the complete dataset
is aligned, we check evaluate whetherwe resample all MRI volumes to the image spacing is
the desired (0.416x0.416x0.399mm) and resample it in case we encounter a different spatial
resolution (0.480x0.480x0.499mm) Afterwards, we compute a voxel signed distance map of
the different labeled regions and fuse them to create the baseline atlas.
To reduce the bias towards a certain shape, we register the baseline atlas against each manually
segmented region using a non-rigid free diffeomorphic demons, and apply the transformation
to the baseline atlas. This process enables us to combine all the deformation fields together
and transform the current baseline atlas into an unbiased NCS atlas.
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A.2 Point-Based Shape Variation Model (PBSVM)
Once the atlas in NCS has been built, we extract a surface point cloud for every eye atlas
region: sclera + cornea, vitreous humor and lens. To obtain this information, we utilize a
mesh extraction algorithm [108]. It is important to highlight that the binary mesh extraction
step generally provides us with a non-smoothed point based surface; therefore, to have a
proper smoothed point distribution, we require to apply a Gaussian smoothing filter [137].
The number of iterations that we do over each surface is 50, with a band-pass filter of 0.01.
The current point cloud represents a smoothed approximation of the original NCS atlas shape.
We apply a decimation to each of the point cloud surfaces [108] and reduce the number of
points to a 15% of the original amount for the sclera + cornea and the vitreous humor, and to a
90% of the original amount for the lens. These new set of points will later be used as landmarks
to capture the patient variability. An important remark concerning the decimation process is
that the algorithm aims at preserving the topology of the surface, therefore, it will preserve
important details, such as the point curvature.
Once the surfaces are decimated, we perform a non-rigid free diffeomorphic demons regis-
tration between the original volumes and the NCS atlas, and warp the atlas landmark point
cloud back to the patients [107]. This process enables us retrieve information about every
landmark position in each the patient. The corresponding landmark positions are used to
capture the landmark variability, which is later encoded inside the PBSVM through a Principal
Component Analysis (PCA)[109]. To perform this process, we start by transforming the point
cloud into a tangent space (Eq. A.1), thus preserving the linearity of the shape (Eq. A.1)
xt = |x|
2
x ∗x · x, (A.1)
This approach follows the lines of Cootes et al. [67], where x¯ is the original surface points vector,
is the mean surface shape and xt is the new projection of the surface points in the tangent
space. We then compute the PCA of the projection, and extract the principal components of
the landmark point cloud distribution in the space. This extracted information is stored in the
form of
x ≈ x¯+Φbi (A.2)
where x¯ is the mean shape, represented as a vector of t points, Φ= (ϕ1|ϕ2|...|ϕt ) is a matrix
which contains the eigenvectors corresponding to the variation of the model at each point
and b is a t-dimensional vector representing the modes of variation, and is widely know as
point based shape variation model (PBSVM). This PBSVM is normally constrained between
the values ±3
√
λi , i = 1..t , to be within the range of similar shapes to the ones used during the
model construction.
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To apply these constraints, we assume that the shapes are represented as a normal distribution
of points across subjects. We could arbitrarily relax the region constraints and increase the
maximum allowed deformation, however, we opted to limit it and to create a robust model,
able to cope with potential pathologies or abnormalities inside the eye.
A.3 Active Shape Models (ASM)
We combine both the PBSVM and the MRI profile intensity information from the subject
dataset to create an ASM. MRI does not provide homogeneous intensity values across subjects
and structures; therefore, we require a reliable standardization algorithm to equalize the
dataset. The standardization algorithm proposed by Nyul et al. [110] proved to be a simple yet
reliable equalization method.
Then, prior to extracting the image profile information, we perform a set of image pre-
processing techniques. First, we start by applying a gradient anisotropic diffusion filter‘[138]
on the standardized images, with a conductance parameter of 1 and run 15 iterations. The
filter will remove existing MRI noise while preserving important anatomical region edges.
Second, we fix an arbitrary lower and upper threshold and filter the image to remove low and
high intensity information. The objective is to achieve a good contrast between the anterior
chamber and the lens, while preserving a good contrast of the vitreous humor and sclera re-
gion. Finally, we compute both the gradient (with a 1 voxel size kernel) and the Sobel operator
of the windowed image.
The gradient gives us the profile information for the regions of the sclera + cornea and the
vitreous humor. The Sobel operator provides the information about the lens region. Once
processed, we retrieve the landmark point cloud information that we extracted in the previous
(PBSVM) section and select an even distribution of points [111] over the surface of the different
layers. We extract 350 points for the regions of the sclera + cornea and the vitreous humor and
300 points for the region of the lens.
The corresponding landmark point clouds across subjects allow us to extract the profiles
normal to the surface and compute the mean profile intensity (for both Gradient and Sobel)
and the covariance matrix across profiles.
The length of the profile depends on the region of interest. For the region of the sclera + cornea
and the vitreous humor we select a profile length of 11 voxels. For the region of the lens we
select a profile length of 9 voxels. An important remark concerning the profile extraction step
is that whenever we encounter a profile whose Gradient/Sobel is not strong enough, we do
not include it in the model. This profile selection process allows us to actively build the model
with the strongest Gradient/Sobel profiles and increase the quality of the fitting during the
automatic segmentation stage.
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EyeModeler : A C++ Framework for
Medical Image Analysis of the Eye
This annex covers the EyeModeler. A software that was developed during this PhD in order to
support clinicians during the evaluation of ocular images, independently of the modality of
use (e.g. MRI, Fundus, US, CT, ...), towards a multimodal navigation system for evaluating eye
diseases. The tool is based on a framework called Marvin [139], a C++ library developed in
collaboration with the University of Bern, and a combination of widely know software libraries
in medical imaging and computer vision (ITK 1, VTK2, QT Creator3, Coin 3D4 and OpenCV5).
The code was written in C++ to increase acceptance in the medical community thanks to its
efficiency and reliability.
B.1 Software notes
The software is ready to be installed in multiple platforms, including:
• Linux - Ubuntu 12.04, 14.04 or superior,
• Mac OS X 10.8 or superior and
• Windows 7 ®.
1 Insight Segmentation and Registration Toolkit (ITK) - http://itk.org/
2 The Visualization Toolkit (VTK) - http://www.vtk.org/
3 QT Creator is a cross-platform C++, JavaScript and QML integrated development environment for QT -
https://www.qt.io/
4 Coin3D is a retained-mode toolkit for effective 3D graphics development Coin3D
5 OpenCV is a library for high-performance computer vision and mathematical processing - http://opencv.org/
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It is divided into several modules that enable the user to load imaging data (MRI, Fundus,
. . . ), annotate information relevant to the patient, build Active Shape Models (ASMs) out of
manual delineations of patient eye structures and to do the automatic segmentation of the
eye in 3D MRI [2]. Furthermore, the software is designed as to be organ/shape independent,
thus, it could be utilized for building statistical models for any shape from which 2D/3D
delineations are present.
In addition, we contributed to prepare the multimodal fusion framework developed in De
Zanet et al. [94] to be used as an additional module in EyeModeler. In the future this work
could be easily deployed alongside the multimodal fusion of pathological MRI and Fundus,
still under development and to be added in future releases of EyeModeler.
B.2 Modules
EyeModeler is organized into different modules, facilitating the user to work with specific tools
depending on his needs. The different modules and submodules are:
Patient Manager : This module is the starting point for loading patient information into the
system. It allows for the creation of patient profiles, to connect different image modalities
from the file system to the patient entry and to create study groups for testing and evaluation.
Once the information is loaded, handling of patients accross studies becomes easy and
import/export of loaded data between multiple EyeModeler users is possible. Fig. B.1 shows a
screenshot of the landing patient manager module.
Figure B.1 – Patient Manager : Module for data loading and archiving. The results from
different experiments are stored as part of the patient information folder.
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MRI Model Building Module : The MRI model building section contains all the methods
for creating a new ASM out of annotated patient information (labels and MRI volumes). It is
connected to the patient manager module in order to load annotations from the file system.
The whole processing diagram is shown in Fig.B.2, and is divided in the following consecutive
steps:
• Load MRI Volumes : Loads the nifti/jpeg file list from the local computer path and
processes the images into a format defined as mvnImage. This format is used within
EyeModeler to ease the process of representation and transformation of medical se-
quences. The images may be composed of manual labels, for generating the shape, or
MRI sequences, containing the profile intensity information.
• Resize MRI Volumes (Optional) : This function accounts for the resizing of the aforemen-
tioned volumes, towards a common reference resolution. As stated in chapters 2 and 3,
in this PhD we worked with datasets of images with varying sizes and resolution, thus,
resizing was required.
• Calculate Distance Maps : In here, we compute the signed distance maps from the
labeled volumes, creating an atlas by simple averaging. All these procedures follow the
structure proposed by Frangi et al. [105] and Cootes et al. [67].
Figure B.2 – MRI Model Building : In this section we focus on generating the Active Shape
Model that best represents the annotated data prior to the MRI segmentation. We created a
set of sequential steps for storing intermediate results whenever evaluation is required.
• Build Atlas from MRI : This function operates once the average atlas has been created.
We apply the Diffeomorphic Demons registration algorithm [107] in order to register
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the average atlas to each patient, and store the deformation fields. The number of
iterations and all the parameters specific to the registration algorithm can be fine-tuned
depending on the requirements of the user. Alternatively, the default parameters are the
ones used in chapters 2 and 3.
• Transform Atlas into NCS : This function computes the deformation field that connect
each patient and the atlas, adding them together aand applying them to the average atlas.
The resulting atlas becomes the new atlas in Natural Coordinates System (NCS) [105].
• Landmark Extraction : Once the process for generating the atlas in NCS is completed,
we use marching cubes [108] to extract the landmarks representing the atlas surface.
On a general basis, the landmarks will have far more point than those required to
fully characterize the shape, thus, a decimation process will be conducted. All the
intermediate hyperparameters can be fine-tuned to maximize the final results.
• Landmark Propagation : This method coregisters the NCS atlas against every patient
using diffeomorphic demons and stores the deformation field. Afterwards, this transfor-
mation is applied to the selected group of landmarks from the NCS atlas.
• Setup Statistical Shape Model (SSM) : This function takes into consideration the spatial
transformation from the previous steps, and allows us to compute a Principal Compo-
nent Analysis (PCA) on the landmark points, towards encoding the Point-Based Shape
Variation Model (PBSVM). The implicit deformation of the point cloud will contain the
shape variations present in our dataset.
• Compute Patient Profile : Once the model shape is modelled, we extract the intensity
profiles normal to every landmark wrt. the shape formed by the surrounding points for
all patients. The intensity information, stored as a vector of profiles accross subjects,
will be encoded together with its specific landmark variability and stored inside the
ASM.
• Setup Profile Model : Finally, after computing all the aforementioned methods, we store
the model as model.xml file. The model is stored as an xml to foster easy transfer with
other research groups or accross experiments.
MRI Segmentation : The present module introduces the fully automatic segmentation of
the eye in 3D MRI. It contains a navigation window and a set of methods to explore the loaded
volume and the different labeled regions (e.g. the sclera, the cornea, the vitreous humor and
the lens for this project). Furthermore, it has an in-built clipping plane functionality that
allows an easy transversal cut of multiple layers, creating an overlap of the model shape and
the MRI cutting planes (see Fig. B.3).
• Load Patient MRI : This method takes care of loading the patient MRI volume and to
represent it in the navigation window. Prior to loading a volume, the path to the file
needs to be introduced in the system via the patient manager.
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• Crop Volume : Once the volume is loaded, the user may decide to work exclusively with
the Region of Interest (ROI). To this, we allow for an automatic cropping of the eye region,
as presented in [?, 2]. The cropping will generate one or two new volumes representing
the eyes and will connect them to the specific patient entry from the patient manager.
• Load Model : This method loads the selected model from the list (generated in the MRI
Model Building Module) into the system to prepare the automatic segmentation of the
eye.
• Initialize Model : This function initializes the previously loaded model and prepares
it for the fitting. That is, we perform all the necessary image processing techniques in
order to prepare the volume for the automatic segmentation. The different steps are:
intensity windowing, histogram equalization and curvature anisotropic filtering [138].
Furthermore, we give the user the possibility to modify the intensity scale, towards
improving the final edge detection used to extract the profiles.
Figure B.3 – MRI Model Segmentation : In here we cover the automatic segmentation of 3D
MRI. The software is ready to load volumes, crop them, select the region of the eyes and
perform series of image processing steps before doing the automatic segmentation. The whole
process takes on average 14s [2]. The green shape represents the model shape in NCS.
• Fit Model : This method proceeds to do the automatic segmentation by minimizing
the Mahalanobis distance between the learn ASM intensity profiles and the current
volume to segment. Deformations of the model follow in an iterative process until either
reaching convergence or the maximum number of iterations.
• Segmentation Error : Segmentation errors allows to compare the current 3D MRI
segmentation with the one defined by the clinician, in case that the user has the Ground
Truth (GT) at disposition.
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• Propagate Cropping : In order to perform the automatic segmentation of ocular tumors
presented in chapter 3, it is desirable to have all the volumes in the same resolution,
orientation and size. This method will processes the volume and store the results in a
common reference spacing and size.
• Eigenmode Selection : This last method permits to evaluate the different modes of
variation create during the PCA decomposition, while building the ASM.
The remaining information from the navigation system indicates the average distance to the
mean shape in mm, and is represented as a color bar on the middle-right side of the screen.
Moreover, the remaining contents of this thesis was implemented in Matlab ®and Python,
and it is not still a functional part of the EyeModeler.
B.3 Conclusions and Future work
This software introduces a new tool for assessing the treatment planning and decision making
process in ocular tumors. Our goal is to be able to provide the scientific community with a set
of tools that clinicians can use in their daily work and to improve the analysis and evaluation
of the disease. Previous tools allowed for the automatic delineation of eye structures on the
assumption that the eye was defined as a parametric spherical shape [49], however, this is, to
our knowledge, the first attempt to present a method for the segmentation of eye structure in
MRI. Furthermore, the software is under constant development is being used by the research
group performing Proton Theraphy for uveal melanoma, in the Paul Scherrer Institute, Villigen,
Switzerland.
In the future we will also integrate the automatic segmentation of ocular tumors and the
multimodal fusion developed in section 4 as additional modules for the EyeModeler. The
ultimate goal of this application is to combine the techniques and the proposed registra-
tion/segmentation methods developed during this work in order to fuse multiple image
modalities into a multi-modal patient specific eye model. By doing so, clinicians from a
various background would be able to share visions and opinions in a simultaneous manner,
towards easing the decision process during the treatment plan.
A few more screenshots of the current software can be observed in Fig. B.4. And a working
video-demo of the software can be seen in this link 6.
6 Automatic Segmentation of the eye in 3D MRI video : https://youtu.be/l_AoUTtWeo8
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Figure B.4 – EyeModeler : EyeModeler navigation systems allows clinicians to explore different
segmentation methods and to perform automatic segmentation of healthy and pathological
eyes on the MRI.
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